<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6869251</article-id><article-id pub-id-type="publisher-id">6265</article-id><article-id pub-id-type="doi">10.1186/s12864-019-6265-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Infection and RNA-seq analysis of a zebrafish <italic>tlr2</italic> mutant shows a broad function of this toll-like receptor in transcriptional and metabolic control and defense to <italic>Mycobacterium marinum</italic> infection</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hu</surname><given-names>Wanbin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yang</surname><given-names>Shuxin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Shimada</surname><given-names>Yasuhito</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>M&#x000fc;nch</surname><given-names>Magnus</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Mar&#x000ed;n-Juez</surname><given-names>Rub&#x000e9;n</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Meijer</surname><given-names>Annemarie H.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4128-9501</contrib-id><name><surname>Spaink</surname><given-names>Herman P.</given-names></name><address><email>h.p.spaink@biology.leidenuniv.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2312 1970</institution-id><institution-id institution-id-type="GRID">grid.5132.5</institution-id><institution>Institute of Biology, Leiden University, </institution></institution-wrap>P.O. Box 9505, 2300 RA Leiden, the Netherlands </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0483 7922</institution-id><institution-id institution-id-type="GRID">grid.458489.c</institution-id><institution>Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, </institution></institution-wrap>Shenzhen, 518055 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0372 555X</institution-id><institution-id institution-id-type="GRID">grid.260026.0</institution-id><institution>Department of Integrative Pharmacology, </institution><institution>Mie University Graduate School of Medicine, </institution></institution-wrap>Tsu, Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2312 1970</institution-id><institution-id institution-id-type="GRID">grid.5132.5</institution-id><institution>Mathematical Institute, Leiden University, </institution></institution-wrap>Leiden, the Netherlands </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution>Department of Epidemiology &#x00026; Biostatistics, </institution><institution>Amsterdam Public Health Research Institute, Amsterdam University Medical Center, </institution></institution-wrap>Amsterdam, the Netherlands </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0491 220X</institution-id><institution-id institution-id-type="GRID">grid.418032.c</institution-id><institution>Department of Developmental Genetics, </institution><institution>Max Planck Institute for Heart and Lung Research, </institution></institution-wrap>Ludwigstrasse 43, 61231 Bad Nauheim, Germany </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>20</volume><elocation-id>878</elocation-id><history><date date-type="received"><day>12</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>5</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The function of Toll-like receptor 2 (TLR2) in host defense against pathogens, especially <italic>Mycobacterium tuberculosis</italic> (Mtb) is poorly understood. To investigate the role of TLR2 during mycobacterial infection, we analyzed the response of <italic>tlr2</italic> zebrafish mutant larvae to infection with <italic>Mycobacterium marinum</italic> (Mm), a close relative to Mtb, as a model for tuberculosis. We measured infection phenotypes and transcriptome responses using RNA deep sequencing in mutant and control larvae.</p></sec><sec><title>Results</title><p id="Par2"><italic>tlr2</italic> mutant embryos at 2 dpf do not show differences in numbers of macrophages and neutrophils compared to control embryos. However, we found substantial changes in gene expression in these mutants, particularly in metabolic pathways, when compared with the heterozygote <italic>tlr2</italic><sup>+/&#x02212;</sup> control. At 4&#x02009;days after Mm infection, the total bacterial burden and the presence of extracellular bacteria were higher in <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> larvae than in <italic>tlr2</italic><sup>+/&#x02212;</sup>, or <italic>tlr2</italic><sup><italic>+/+</italic></sup> larvae, whereas granuloma numbers were reduced, showing a function of Tlr2 in zebrafish host defense. RNAseq analysis of infected <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> versus <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> shows that the number of up-regulated and down-regulated genes in response to infection was greatly diminished in <italic>tlr2</italic> mutants by at least 2 fold and 10 fold, respectively. Analysis of the transcriptome data and qPCR validation shows that Mm infection of <italic>tlr2</italic> mutants leads to decreased mRNA levels of genes involved in inflammation and immune responses, including <italic>il1b</italic>, <italic>tnfb</italic>, <italic>cxcl11aa/ac</italic>, <italic>fosl1a</italic>, and <italic>cebpb</italic>. Furthermore, RNAseq analyses revealed that the expression of genes for Maf family transcription factors, vitamin D receptors, and Dicps proteins is altered in <italic>tlr2</italic> mutants with or without infection. In addition, the data indicate a function of Tlr2 in the control of induction of cytokines and chemokines, such as the CXCR3-CXCL11 signaling axis.</p></sec><sec><title>Conclusion</title><p id="Par3">The transcriptome and infection burden analyses show a function of Tlr2 as a protective factor against mycobacteria. Transcriptome analysis revealed <italic>tlr2</italic>-specific pathways involved in Mm infection, which are related to responses to Mtb infection in human macrophages. Considering its dominant function in control of transcriptional processes that govern defense responses and metabolism, the TLR2 protein can be expected to be also of importance for other infectious diseases and interactions with the microbiome.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Tuberculosis</kwd><kwd>Mycobacterium</kwd><kwd>TLR2</kwd><kwd>RNAseq</kwd><kwd>RNA deep sequencing</kwd><kwd>Transcriptomics</kwd><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004543</institution-id><institution>China Scholarship Council</institution></institution-wrap></funding-source><award-id>2017</award-id><award-id>2012</award-id><principal-award-recipient><name><surname>Hu</surname><given-names>Wanbin</given-names></name><name><surname>Yang</surname><given-names>Shuxin</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par21"><italic>Mycobacterium tuberculosis</italic> (Mtb) is the causative agent of tuberculosis (TB), which infects nearly 23% of the world&#x02019;s population, and kills about 1.6 million people annually (WHO Global Tuberculosis Report 2018). TB is characterized by the formation of granulomas, aggregates of infected macrophages and other immune cells, not only in the lung but also in other tissues and organs [<xref ref-type="bibr" rid="CR1">1</xref>]. The formation of granulomas is the result of a concerted action of host innate and adaptive immunity [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par22">Innate immune responses play a critical role in defense against TB infection in the host, and for a major part these processes are mediated by Toll-like receptors (TLRs), a conserved family of pattern recognition receptors. TLR2 is one of the most widely reported members of the TLR family to be involved in defense against Mtb by virtue of its recognition of cell wall-associated components associated with this pathogen [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Following mycobacterial infection in human cell cultures, TLR2 dimerizes with TLR1 or TLR6, and recognizes mycobacterial components such as cell wall glycolipids LAM and LM [<xref ref-type="bibr" rid="CR8">8</xref>], 38-kDa and 19-kDa mycobacterial glycoprotein (LpqH) [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>], phosphatidylinositol mannoside (PIM) [<xref ref-type="bibr" rid="CR12">12</xref>], and triacylated (TLR2/TLR1) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] or diacylated (TLR2/TLR6) lipoproteins [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Then, these heterodimers recruit the MYD88 and TIRAP (MAL) proteins to activate the IRAK (1 and 4)/TRAF6/IKK (&#x003b1; or &#x003b2;) cascade, which subsequently leads to the ubiquitination of I&#x003ba;B&#x003b1; and the activation of transcription factor NF-&#x003ba;B or AP-1 to induce the expression of host defense genes and cytokine and chemokine responses [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Once released after further processing, these cytokines and chemokines attract migration of macrophages and neutrophils to the infection site and activate the microbicidal functions of these cells.</p><p id="Par23">TLR2 has been shown to be important for granuloma formation in Mtb infection in mouse infection model [<xref ref-type="bibr" rid="CR19">19</xref>]. Other studies have reported that <italic>Tlr2</italic><sup>&#x02212;/&#x02212;</sup> mice lose control to high dose infection of Mtb delivered by aerosol administration and show higher susceptibility to Mtb infection compared to the wild type [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. However, using lower doses of infection of 100 bacteria, there are controversial results as to the function of TLR2 in defense to Mtb in rodent models [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>]. Furthermore, the function of TLR2 in susceptibility to Mtb is still unclear because several independent studies have reported polymorphisms of TLR2 (TLR1 and TLR6) in humans that have been linked with TB susceptibility, whereas others have been unable to find such links [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par24">Several studies suggest that the interaction between TLR2 and Mtb or other pathogens does not always promote the killing of bacteria, but can in fact be part of the pathogens&#x02019;s strategy to evade the immune system [<xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. TLR2 has been reported to inhibit MHC-II expression on the surface of murine macrophages, thereby preventing presentation of Mtb antigens, which may allow intracellular Mtb to evade immune surveillance and maintain chronic infection [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Furthermore, LprG from Mtb was reported to inhibit human macrophage class II MHC antigen processing through TLR signaling [<xref ref-type="bibr" rid="CR25">25</xref>]. In other infection systems, <italic>Tlr2</italic> mutant mice have an increased resistance against infection of <italic>Candida albicans</italic> [<xref ref-type="bibr" rid="CR29">29</xref>] and <italic>Yersinia pestis</italic> [<xref ref-type="bibr" rid="CR30">30</xref>]. It has been proposed that this phenotype is the result of Tlr2-dependent induction of the anti-inflammatory cytokine IL-10 [<xref ref-type="bibr" rid="CR30">30</xref>]. Furthermore, TLR2 activation inhibits the release of IL-12 via activation of the cFos transcription factor. It also has been shown that IFN-&#x003b3; or IFN-&#x003b3;-induced signals [<xref ref-type="bibr" rid="CR31">31</xref>] are inhibited after infection of murine macrophages in a Tlr2-dependent fashion [<xref ref-type="bibr" rid="CR32">32</xref>]. These effects show that TLR2 activation can yield a bias to T helper Type 2 (Th2) cells [<xref ref-type="bibr" rid="CR33">33</xref>], and by breaking the Th1/Th2 balance can lead to less Th1 type responses and reducing the killing of intracellular pathogens. However, most of the molecular mechanisms underlying TLR2 functions remain unknown and a better understanding of the TLR2-mediated immune response and immune evasion can help in planning prevention and therapy strategies against Mtb infection.</p><p id="Par25">Animal models have shown their power in studies of the mechanisms of interaction of host and TB pathogens, and discovering new anti-TB drugs. Zebrafish adult and larvae models have become a useful complement for rodent studies, for three important reasons. First, zebrafish have a 3&#x02013;4&#x02009;weeks separation stage between development of innate and adaptive immunity after fertilization [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], which gives the possibility to study the host innate immune response to infection in the absence of adaptive immune responses. Second, zebrafish can be infected by <italic>Mycobacterium marinum</italic> (Mm), a natural pathogen of cold-blooded vertebrates and a close relative of Mtb, which can induce granuloma formation in zebrafish, similar to human TB [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Third, the transparent larvae are ideal for imaging the early steps of the infection process in real time. Hence, zebrafish has earned its place of being a versatile tuberculosis model [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Although zebrafish has no lungs and therefore the route of infection is through other tissues, it has been shown that the parasitism of immune cells and the aggregation of infected cells into granulomatous aggregates are highly similar to that in mammals [<xref ref-type="bibr" rid="CR40">40</xref>]. Nevertheless, there are some notable difference with the progression of the tuberculosis infection processes in mice [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par26">The TLR signaling pathway in zebrafish appears to be highly conserved with that in mammals [<xref ref-type="bibr" rid="CR42">42</xref>]. The zebrafish <italic>tlr2</italic> gene and the genes encoding its adaptor proteins are highly similar in sequence to those of mammals and mutation of the down-stream signaling gene <italic>myd88</italic> leads to phenotypes that correlate with those seen in rodent and human cell culture studies [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. In our previous study, we demonstrated that the mammalian TLR2 ligand Pam3CSK4, a synthetic triacylated lipopeptide that mimics the triacylated lipoprotein of mycobacteria, could also specifically activate the zebrafish Tlr2 pathway, inducing <italic>fosl1a</italic> and <italic>cebpb</italic> gene upregulation [<xref ref-type="bibr" rid="CR45">45</xref>]. In the current study, to further explore the involvement of Tlr2 in Mm infection, we conducted infection studies using <italic>tlr2</italic> mutant zebrafish. We found that a <italic>tlr2</italic> mutation led to an overall increased Mm bacterial burden, corresponding with reduced presence of macrophages in the granulomatous aggregates and more extracellular growth. These results indicate that Tlr2 plays an important role in protecting the host during the early stage of mycobacterial infection. In addition, we performed RNA deep sequencing (RNAseq) and determined a Tlr2-specific gene list for the response to Mm infection. This analysis revealed that most of transcriptional downregulation caused by Mm infection in control animals was abrogated by <italic>tlr2</italic> mutation, in addition to a dampening effect on the upregulation of transcription factors and inflammatory genes.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Characterisation of a <italic>tlr2</italic> mutant zebrafish line</title><p id="Par27">The <italic>tlr2</italic><sup>sa19423</sup> mutant (<italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup>) carries a thymine to adenine point mutation that creates a premature stop codon (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a), which is located in the sequence coding for the C-terminus of the leucine-rich repeat (LRR) domain. This leads to a truncated protein without the Toll/IL-1 receptor (TIR) domain, which is required for the interaction with Myd88 and Tirap (Mal) [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].
<fig id="Fig1"><label>Fig. 1</label><caption><p>Characterization of the Tlr2 mutant. <bold>a</bold> mutant DNA and protein sequence. A point mutation (T to A) in the C-terminal of the second LRR domain of zebrafish Tlr2 introduces a premature stop codon. The predicted truncated protein lacks the whole TIR domain. Nucleotide and amino acid positions are indicated with respect to the translation start codon. <italic>tlr2</italic><sup><italic>+/+</italic></sup>, <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> embryos were injected at 27 hpf with 1&#x02009;ng Pam3CSK4 (<bold>b</bold>-<bold>d</bold>) or 0.1&#x02009;ng flagellin (<bold>e</bold>-<bold>g</bold>) and expression levels of <italic>il1b</italic>, <italic>fosl1a</italic> and <italic>cebpb</italic> were determined at 1&#x02009;h post injection by qPCR. Data (mean&#x02009;&#x000b1;&#x02009;SEM) are combined from three biological replicates (<italic>n</italic>&#x02009;=&#x02009;10 embryos per group) and expressed relative to their corresponding mock injection (water) control (ctrl), which is set at 1. Statistical significance of differences between ctrl and PAMPs injection groups was determined by two-way ANOVA with Tukey&#x02019;s Multiple Comparison method as a post-hoc test (<bold>b</bold>-<bold>g</bold>), ns, non-significant; *, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; ***, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; ****, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. <bold>h</bold>, <bold>i</bold>. Representative Stereo images of the caudal hematopoietic tissue of <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> (<bold>h</bold>) and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> (<bold>i</bold>) were taken at 2 dpf for quantification of macrophages and neutrophils numbers. At 2 dpf, numbers of mCherry-labeled macrophages (<bold>j</bold>) and GFP-labeled neutrophils (<bold>k</bold>) were counted using Leica TCS SP8 confocal laser scanning microscopy (CLSM) of transgenic lines. Data (mean&#x02009;&#x000b1;&#x02009;SEM) were combined from two independent experiments. No significant differences (ns) in the number of macrophages (<bold>j</bold>) and neutrophils (<bold>k</bold>) was detected with a t-test</p></caption><graphic xlink:href="12864_2019_6265_Fig1_HTML" id="MO1"/></fig></p><p id="Par28">To confirm whether <italic>tlr2</italic> mutation blocks its downstream pathway, we analyzed the gene expression profiles of zebrafish treated with the TLR2 agonist, Pam3CSK4 similarly as in our previous work [<xref ref-type="bibr" rid="CR48">48</xref>], now also including the heterozygote mutant (<italic>tlr2</italic><sup>+/&#x02212;</sup>). Pam3CSK4 was injected into the blood island of zebrafish embryos at 27&#x02009;h post fertilization (hpf). One hour after injection (hpi), we collected samples and performed qPCR to analyze the expression levels of CCAAT/enhancer-binding protein beta (<italic>cebpb</italic>) and FOS Like Antigen 1a (<italic>fosl1a</italic>), previously shown to be specific targets of Tlr2 signaling [<xref ref-type="bibr" rid="CR45">45</xref>]. In wild-type siblings and <italic>tlr2</italic><sup><italic>+/</italic> sa19423</sup> heterozygotes (<italic>tlr2</italic><sup><italic>+/</italic>&#x02212;</sup>), the expression levels of <italic>cebpb</italic> and <italic>fosl1a</italic>, as well as the inflammatory gene <italic>il1b</italic> were significantly induced upon Pam3CSK4 injection, whereas <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> showed no significant response (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b-d). <italic>tlr2</italic><sup><italic>+/</italic>&#x02212;</sup> animals showed a lower induction of these marker genes than the wild-types, indicating that there is an effect of the <italic>tlr2</italic> mutation even in the heterozygote. To confirm that these results are specific to the Tlr2 pathway, we injected flagellin, a Tlr5 agonist, into 27 hpf embryos. Flagellin induced <italic>il1b</italic> expression, but not <italic>cebpb</italic> and <italic>fosl1a</italic> expression in wild-type siblings, <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> larvae (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>e-g). Overall, these data show that <italic>tlr2</italic> mutation specifically blocks the Tlr2 downstream pathways.</p><p id="Par29">To determine if immune cell development was affected by <italic>tlr2</italic> mutation, we used the double-transgenic line <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> to count the number of macrophages and neutrophils at 2 dpf. The results show that there is no significant difference in the number of macrophages and neutrophils at 2 dpf between the wild type and mutant (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>j, k)<italic>.</italic></p></sec><sec id="Sec4"><title>Comparison of gene expression profiles of <italic>tlr2</italic> homozygote and heterozygote mutants in the absence of infection</title><p id="Par30">In order to investigate the systemic effects of the <italic>tlr2</italic> mutation we compared basal levels of gene expression in the absence of infection between <italic>tlr2</italic> homozygote and heterozygote mutants (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). We chose to use the heterozygote <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> line as a control since these are genetically as comparable as possible, considering the fact that random ENU mutations could still contaminate our background even after 3 generations of outcrossing and the use of sibling lines. To further minimize the effect of polymorphisms, we pooled 10 larvae in each of our samples. These results show that there is a large group of genes that are expressed differently even at extremely stringent false discovery rate (FDR) adjusted <italic>p-</italic>value of 10<sup>&#x02212;&#x02009;10</sup> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Since the results of the DEseq2 analyses showed such a surprisingly large number of significant differences we also used another statistical method for analyses, called edgeR, that differs in normalization and estimation of the dispersion parameters [<xref ref-type="bibr" rid="CR49">49</xref>]. EdgeR analyses confirmed the statistical significance of the differences between the homozygote and heterozygote mutants (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a and b). While no differences in numbers of mpeg-positive macrophages were detected (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>j, k), the RNAseq analysis showed that the <italic>mpeg1</italic> gene is expressed approximately 2 fold higher in the <italic>tlr2</italic><sup>+/&#x02212;</sup> control than in the <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> mutant (Additional&#x000a0;file&#x000a0;<xref rid="MOESM12" ref-type="media">12</xref>: Table S1). This was confirmed by pixel count measurements in the transgenic line <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1 a, b)<italic>.</italic> These results showed lower fluorescence of the mCherry <italic>mpeg1</italic> reporter as compared to the wild-type siblings at 2 dpf (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1 a) whereas no difference was detected for the eGFP <italic>mpx</italic> reporter (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1 b). Therefore these in vivo results confirm the RNAseq data. We also examined the expression levels of the <italic>tlr2</italic> gene in the homozygote and heterozygote mutants in the RNAseq data (Additional&#x000a0;file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Figure S2). The results show that, although <italic>tlr2</italic> is very lowly expressed, there is no difference in expression levels between the homozygote and heterozygote mutants, indicating that there is no non-sense mediated mRNA decay (NMD).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Gene expression in the absence of infection between Tlr2 mutants. <bold>a</bold> a number of down- and up-regulated genes per method (edgeR and DEseq2) and <bold>b</bold> a Venn diagram that compares the down-, up- and non-differentially expressed genes per method at a significance level of 10<sup>&#x02212;&#x02009;10</sup> in the edgeR and DEseq2 analyses methods. Down-regulated means that a gene is less expressed in the <italic>tlr2</italic><sup>+/&#x02212;</sup> compared to the <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> strain</p></caption><graphic xlink:href="12864_2019_6265_Fig2_HTML" id="MO2"/></fig></p><p id="Par31">To investigate whether the basal expression level differences of genes might be relevant to the Tlr2 pathway, we performed GO analysis of a set of genes that were expressed differently with the very low FDR adjust <italic>P</italic> value of 10<sup>&#x02212;&#x02009;10</sup> (Additional&#x000a0;file&#x000a0;<xref rid="MOESM13" ref-type="media">13</xref>: Table S2). Gene ontology analyses of the gene sets that differ with an FDR of 10<sup>&#x02212;&#x02009;10</sup> in both analyses show that there is a large enrichment of genes belonging to the GO terms related to neural development (Additional&#x000a0;file&#x000a0;<xref rid="MOESM13" ref-type="media">13</xref>: Table S2). In addition, we have also analyzed differences with a fold change criterion of two and FDR of 0.05. These analyses indicated that under the GO category &#x0201c;Transcription factor genes&#x0201d; only two categories of genes including the c-Maf transcription factor were present (Additional&#x000a0;file&#x000a0;<xref rid="MOESM14" ref-type="media">14</xref>: Table S3). Pathway analysis shows that genes that function in glucose metabolism are differentially expressed in the <italic>tlr2</italic> homozygote versus heterozygote mutant (Additional&#x000a0;file&#x000a0;<xref rid="MOESM3" ref-type="media">3</xref>: Figure S3).</p></sec><sec id="Sec5"><title>Tlr2-specific gene expression profiles after Mm infection</title><p id="Par32">To study the role of Tlr2 in Mm infection we tested the <italic>tlr2</italic> mutant line in comparison with the heterozygote and wild-type sibling controls (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). No differences in bacterial burden were observed at 3 dpi (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d). However, we found that bacterial burden was significantly higher in <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> than in <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and wild-type larvae at 4 dpi (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>e). There was no significant difference in bacterial infection burden between the heterozygote mutant strain (<italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup>) and the wild-type siblings (<italic>tlr2</italic><sup><italic>+/+</italic></sup>). At 4 dpi, <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> larvae showed a significantly decreased percentage of survival compared with <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and wild-type larvae (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>f). There was no significant difference in percentage of survival between <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and wild-type larvae at 4 dpi. For further analysis of the infection phenotype we performed confocal laser scanning microscopy (CLSM) in the <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg (mpeg1:EGFP), tlr2</italic><sup><italic>+/&#x02212;</italic></sup>
<italic>Tg (mpeg1:EGFP)</italic> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg (mpeg1:EGFP</italic>) transgenic lines in which macrophages are fluorescently labelled (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a, b and Additional&#x000a0;file&#x000a0;<xref rid="MOESM4" ref-type="media">4</xref>: Figure S4). The results using fluorescent automated pixel count analyses showed that in the <italic>tlr2</italic> mutant the number of bacteria that were not present within macrophages was significantly higher than in the heterozygote and wild-type sibling controls (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). We also observed by manual counting that in the <italic>tlr2</italic> mutant a significantly higher number of bacteria in large extracellular clusters (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d), indicative for cording structures [<xref ref-type="bibr" rid="CR50">50</xref>]. Manual counting of infected macrophage clusters showed a significantly lower number of granulomas in the <italic>tlr2</italic> mutant (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>e). However, the percentage of larvae with at least one granuloma was not different from the heterozygote and wild-type sibling controls (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>f). These results show that the <italic>tlr2</italic> mutation results in a defect in the defense response against mycobacteria at 4 dpi.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Quantification of bacterial burden and survival after <italic>M. marinum</italic> infection. <italic>tlr2</italic><sup><italic>+/+</italic></sup> (<bold>a</bold>), <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> (<bold>b</bold>) and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> (<bold>c</bold>) embryos were infected with mCherry-labeled <italic>M. marinum</italic> strain Mma20 at a dose of ~&#x02009;150&#x02009;CFU by caudal vein infection at 28 hpf. Representative images for bacterial pixel count in <italic>tlr2</italic><sup><italic>+/+</italic></sup> (<bold>a</bold>), <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> (<bold>b</bold>) and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> (<bold>c</bold>) were taken at 4 dpi. Bacterial burden of <italic>tlr2</italic><sup><italic>+/+</italic></sup>, <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> were also quantified at 3 dpi (<bold>d</bold>) and 4 dpi (<bold>e</bold>). Bacterial burdens were quantified by using bacterial fluorescence pixels. Red stars in (<bold>e</bold>) indicate the data for the representative images shown in (<bold>a</bold>-<bold>c</bold>). In (<bold>d</bold>, <bold>e</bold>), data (mean&#x02009;&#x000b1;&#x02009;SEM) were combined from two independent experiments. Statistical significance of differences was determined by one-way ANOVA with Tukey&#x02019;s Multiple Comparison method as a post-hoc test for comparison between more than two groups (<bold>d</bold>, <bold>e</bold>). Percent of survival curves for <italic>tlr2</italic><sup><italic>+/+</italic></sup> (<italic>n</italic>&#x02009;=&#x02009;47), <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> (<italic>n</italic>&#x02009;=&#x02009;49) and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> (n&#x02009;=&#x02009;49) (<bold>f</bold>) are based on two independent experiments. Statistical significance of difference was determined by a log-rank (Mantel-Cox) test. ns, non-significant; *, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ****, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="12864_2019_6265_Fig3_HTML" id="MO3"/></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Quantification of Mma20 infection phenotype in the <italic>tlr2</italic> mutant. Embryos were infected at 28 hpf with ~&#x02009;150&#x02009;CFU&#x02009;<italic>M. marinum</italic> Mma20 strain. Confocal images of green fluorescent macrophages and red fluorescent bacteria in a granuloma of <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg (mpeg1:EGFP)</italic> larva (<bold>a</bold>) and extracellular bacteria in <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg (mpeg1:EGFP)</italic> larva (<bold>b</bold>) was conducted at 4 dpi with 10 (<bold>a</bold>, <bold>b</bold>, bright view images) and 63 (<bold>a</bold>, <bold>b</bold>, fluorescent view images) times magnification objectives. White arrowheads indicates a granuloma (<bold>a</bold>) and extracellular bacteria (<bold>b</bold>). In the bright view images of (<bold>a</bold>, <bold>b</bold>), the scale bar represents 50&#x02009;&#x003bc;m. In the fluorescent view images of (<bold>a</bold>, <bold>b</bold>), the scale bar represents 10&#x02009;&#x003bc;m. For quantification of bacteria outside macrophages by pixel count (<bold>c</bold>) large extracellular clusters of at least 8&#x02009;&#x003bc;m diameter (<bold>d</bold>) and average number of granulomas in the CHT region (<bold>e</bold>) three groups of at least 37 embryos of <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg (mpeg1:EGFP), tlr2</italic><sup><italic>+/&#x02212;</italic></sup>
<italic>Tg (mpeg1:EGFP)</italic> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg (mpeg1:EGFP)</italic> embryos were analysed at 4 dpi in the CHT region. For these CLSM analyses, 20 times magnification was used (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S4 gives representative images). In panel f the percentage of embryos with at least one granuloma in the CHT region is shown. Statistical significance of differences was determined by one-way ANOVA with Tukey&#x02019;s Multiple Comparison method as a post-hoc test for comparison between more than two groups (<bold>c</bold>-<bold>f</bold>). ns, non-significant; * <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; ** <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, **** <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001</p></caption><graphic xlink:href="12864_2019_6265_Fig4_HTML" id="MO4"/></fig></p><p id="Par33">Next, we set out to assess the general inflammation and specific immune responses in <italic>tlr2</italic> mutants. We analyzed these parameters at 4 dpi to correlate transcriptional responses with the first microscopically measured effect of the mutation on the progression of infection process as measured by bacterial burden (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>e). For this, genes that were shown previously to be specifically or aspecifically responding to Pam3CSK4 [<xref ref-type="bibr" rid="CR45">45</xref>] were analyzed by qPCR of <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> and <italic>tlr2</italic><sup>+/&#x02212;</sup> larvae upon Mm (strain Mma20) infection at 4 dpi: <italic>tlr2</italic>-aspecific response genes <italic>il1b</italic>, <italic>tnfa</italic>, <italic>tnfb</italic>, <italic>irg1l</italic>, and <italic>tlr2</italic>-specific response genes <italic>fosl1a</italic> and <italic>cebpb</italic>. Our results show that the induction levels of <italic>il1b</italic>, <italic>tnfb, fosl1a</italic> and <italic>cebpb</italic> in <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> larvae were significantly reduced when compared to the heterozygotes in the infected condition (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). The induction levels of <italic>irg1l</italic> and <italic>tnfa</italic> were less clearly affected. <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> larvae failed to upregulate <italic>fosl1a</italic> and <italic>cebpb</italic> expression in response to Mm administration (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>e, f). In our previous work, we showed that Cxcl11-like chemokines expressed in macrophages play a crucial role in granuloma formation upon Mm infection [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. We therefore conducted qPCR to assess the expression levels of <italic>cxcl11-like</italic> genes, previously shown to be induced by infection [<xref ref-type="bibr" rid="CR51">51</xref>], including <italic>cxcl11aa</italic> and <italic>cxcl11ac</italic> (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>g, h). The expression levels of <italic>cxcl11aa</italic> and <italic>cxcl11ac</italic> was significantly higher in <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> larvae than in <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> upon Mm infection (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>g, h). These results indicate that <italic>tlr2</italic> mutation results in a defective immune or inflammatory response to Mm infection.
<fig id="Fig5"><label>Fig. 5</label><caption><p>Immune genes expression in <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> fish lines infected with Mm. The expression levels of <italic>il1b</italic> (<bold>a</bold>), <italic>tnfa</italic> (<bold>b</bold>), <italic>tnfb</italic> (<bold>c</bold>), <italic>irg1l</italic> (<bold>d</bold>), <italic>fosl1a</italic> (<bold>e</bold>), <italic>cebpb</italic> (<bold>f</bold>), <italic>cxcl11aa</italic> (<bold>g</bold>) and <italic>cxcl11ac</italic> (<bold>h</bold>) were determined at 4dpi by qPCR. Data (mean&#x02009;&#x000b1;&#x02009;SEM) are derived from at least three biological replicates (<italic>n</italic>&#x02009;=&#x02009;10 embryos per group) and expressed relative to their corresponding mock injection (PBS) control, which is set at 1. Statistical significance of differences was determined by two-way ANOVA with Tukey&#x02019;s Multiple Comparison test as a post-hoc test. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001</p></caption><graphic xlink:href="12864_2019_6265_Fig5_HTML" id="MO5"/></fig></p><p id="Par34">To further study the function of <italic>tlr2</italic> in defense against mycobacterial infection, we performed RNAseq of <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> larvae at 4 dpi with <italic>M. marinum</italic> strain (strain Mma20) and PBS as control. We summarized the number of differential expressed genes (DEGs) according to <italic>P-</italic>value (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a, b) and in volcano plots (Additional&#x000a0;file&#x000a0;<xref rid="MOESM5" ref-type="media">5</xref>: Figure S5). The number of DEGs in <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> infected with Mm was higher than those in <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> at any given <italic>P-</italic>value or false discovery rate less than 0.05, or any given fold-change with a <italic>P-</italic>value less than 0.05<italic>.</italic> These data also show that most of the genes downregulated by the Mm infection in the control remained unchanged in <italic>tlr2</italic> mutants (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a, b). To further analyze these RNAseq data, we chose the genes with a threshold of a <italic>P</italic>-value less than 0.05 in <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> with Mm infection (1102 up- and 827 down-regulated genes, Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a). Then, for these genes, we calculated the fold-change ratio of <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> versus <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>, and genes with ratios greater than 2 or less than 0.5 were selected for further analysis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>c). As a result, 97 and 92 genes were scored as <italic>tlr2</italic> specific up- and down-regulated genes, respectively. Next, we conducted GO analysis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d, e) showing that genes grouped into the immune system category are the most prominently deregulated (36%) in the whole <italic>tlr2</italic> up-regulated 97-gene set (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d). Within this category we found genes involved in lysosome, chemotaxis, transcription regulation, diverse immunoglobulin domain-containing proteins (<italic>dicps</italic>) and other immune processes (Figs.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d and <xref rid="Fig7" ref-type="fig">7</xref>a-e). For other categories, many up-regulated genes fell in the categories oxidation-reduction process, DNA repair, transcription regulation and apoptotic process regulation (Additional&#x000a0;file&#x000a0;<xref rid="MOESM6" ref-type="media">6</xref>: Figure S6). In the <italic>tlr2</italic> down-regulated 92-gene set, the immune related genes also were the largest portion (15%; Figs.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>e and <xref rid="Fig7" ref-type="fig">7</xref>f). Many of these genes are poorly annotated and include genes encoding cysteine proteases, a <italic>nitr</italic> gene, a <italic>mafb</italic> transcription factor gene and <italic>hsp70</italic>. Categories encompassing non-immune related genes are listed in Additional&#x000a0;file&#x000a0;<xref rid="MOESM7" ref-type="media">7</xref>: Figure S7. These results show that, upon infection with Mm<italic>, tlr2</italic> mutants show a dampened response of immune genes.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Overview of RNAseq results. <bold>a</bold>, <bold>b</bold> the number of DEGs of <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> strains infected with Mm compared to the control at different <italic>p</italic>-value and fold change. <bold>c</bold>, the work flow of screening genes of which the regulation by infection is dependent on <italic>tlr2</italic>. <bold>d</bold>, GO analysis of the 97 upregulated genes. <bold>e</bold>, GO analysis of the 92 down-regulated genes. FC, fold-change)</p></caption><graphic xlink:href="12864_2019_6265_Fig6_HTML" id="MO6"/></fig>
<fig id="Fig7"><label>Fig. 7</label><caption><p>Overview of fold changes of representative genes selected from the gene categories resulting from GO-term analysis. <bold>a</bold>-<bold>e</bold>: <italic>tlr2</italic>-dependent genes with up regulation corresponding to Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d. <bold>f</bold>: <italic>tlr2</italic> specific genes with down regulation corresponding to Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>e</p></caption><graphic xlink:href="12864_2019_6265_Fig7_HTML" id="MO7"/></fig></p><p id="Par35">To show the relationship between DEGs, we constructed networks based on common expression targets in the 97 up- and 92 down-regulated genes [<xref ref-type="bibr" rid="CR53">53</xref>]. The involved networks with the up-regulated genes contain <italic>lipc</italic>, <italic>nr0b2</italic>, <italic>hmgcr</italic>, <italic>itln1</italic>, <italic>fgf23</italic>, <italic>vdr</italic>, <italic>irak3</italic> and <italic>tlr8</italic> (Additional&#x000a0;file&#x000a0;<xref rid="MOESM8" ref-type="media">8</xref>: Figure S8). In <italic>tlr2</italic><sup>+/&#x02212;</sup> controls we observed positively regulated <italic>hmgcr</italic>, <italic>fgf23</italic>, <italic>vdr</italic> and <italic>tlr8</italic>, and negatively regulated <italic>nr0b2</italic>, whereas <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> showed an opposite regulation for most of these genes. However, <italic>lipc</italic> and <italic>irak3</italic>, were positively regulated in both <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup>. For the 92 downregulated genes, a network containing <italic>nr0b2</italic> and <italic>mafb</italic> was constructed (Additional&#x000a0;file&#x000a0;<xref rid="MOESM9" ref-type="media">9</xref>: Figure S9). <italic>nr0b2</italic> and <italic>mafb</italic> were positively regulated in <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> zebrafish and down regulated in <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup>.</p></sec><sec id="Sec6"><title>Enrichment analysis of Tlr2 specific genes after Mm infection</title><p id="Par36">To link our data to gene sets defined based on prior biological knowledge (including GO), we conducted Gene-Set Enrichment Analysis (GSEA) of the differently expressed genes. This method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation [<xref ref-type="bibr" rid="CR54">54</xref>]. Because the number of predicted gene sets were too large for our analysis method (more than 1000 with <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), we focused on the gene sets related to metabolic, immunological and inflammation pathways. GSEA predicted 61 pathways in <italic>tlr2</italic><sup>+/&#x02212;</sup> and 67 pathways in <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> zebrafish responsive to Mm infection (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4A and 4B). Interestingly, most of these pathways are common in <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup>, however some of them are detected as being anti-correlated in regulation, including some pathways underlying natural killer cell functions and omega-6-fatty acid metabolism (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4C). We also performed Sub-Network Enrichment Analysis (SNEA) [<xref ref-type="bibr" rid="CR55">55</xref>] to identify possible key genes that are responsible for the difference in response of the <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> group to Mm infection (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). SNEA predicted 565 and 503 pathways for <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> zebrafish that are linked to the response to infection, respectively (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4D and 4E), and 264 and 202 of them are specific for the response in <italic>tlr2</italic><sup>+/&#x02212;</sup> and <italic>tlr</italic>2<sup>&#x02212;/&#x02212;</sup> fish, respectively (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4F). Since the RNAseq was conducted with the total RNA from whole body of zebrafish, it is not possible to define which pathways are involved in macrophage functions related to <italic>tlr2</italic> expression. Therefore, we analyzed previously published DNA microarray data (GDS4781) of human macrophages transfected with <italic>Mtb</italic> from Gene Expression Omnibus [<xref ref-type="bibr" rid="CR56">56</xref>]. SNEA analysis of human macrophages shows that 659 pathways are linked to Mtb infection (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4G). By comparing the human SNEA result to <italic>tlr2</italic><sup>+/&#x02212;</sup> specific pathways in zebrafish, 56 pathways were defined as <italic>tlr2</italic><sup>+/&#x02212;</sup>-specific (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4H). Of these, the pathway of TLR8, which has the lowest <italic>P-</italic>value in both zebrafish and human enrichment (Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4H), and its network is depicted as example in Additional&#x000a0;file&#x000a0;<xref rid="MOESM10" ref-type="media">10</xref>: Figure S10. Overall, these analyses show that <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> mutants have a strongly altered immune response of which many pathways that are linked to human tuberculosis are differently responding.</p></sec></sec><sec id="Sec7"><title>Discussion</title><p id="Par37">TLR2 has been shown to play a role in host defense against Mtb in several rodent studies but its role in host innate immunity during infection is still not clear. Moreover, little is known about the systemic regulation of down-stream signaling of TLR receptors in animal models. As part of this study we generated a <italic>tlr2</italic> zebrafish mutant to study Tlr2 function in the innate immune system during mycobacterial infection. Our results show a function of Tlr2 in defense against mycobacterial infection. This function is apparent by a larger number of extracellular bacteria and a lower number of granulomas in the <italic>tlr2</italic> mutant compared to the controls. This result is in agreement with in vivo studies in mice infected with tuberculosis bacteria that show a defect in granuloma formation in a Tlr2 mutant [<xref ref-type="bibr" rid="CR19">19</xref>]. To obtain explanations and genetic markers for further studies of the effect of the <italic>tlr2</italic> mutation on infection we performed deep RNA sequencing to study the whole transcriptome profile in our mycobacterial infection model at the systems level. There are only a few RNA sequencing results of tuberculosis studies in rodents [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], human serum [<xref ref-type="bibr" rid="CR59">59</xref>], human pulmonary epithelial cells [<xref ref-type="bibr" rid="CR60">60</xref>], and bovine systems.</p><p id="Par38">To characterize the effect of <italic>tlr2</italic> mutation in the absence of infection, we compared the transcriptome of homozygous mutant larvae with that of heterozygote larvae, thereby excluding the effect of non-dominant background polymorphisms that might have resulted from ENU mutagenesis. The results show large differences between these genotypes, for instance in genes involved in glycolysis (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Figure S3). In accordance, a previous study in human peripheral blood mononuclear cells and an in vivo mouse model for tuberculosis showed a switch in host cellular metabolism toward aerobic glycolysis after mycobacterial infection that is dependent on TLR2 [<xref ref-type="bibr" rid="CR61">61</xref>]. In agreement, our previous results in zebrafish larvae suggested a role in metabolism also for Myd88, the adaptor in TLR signaling [<xref ref-type="bibr" rid="CR48">48</xref>]. The largest category of genes that was significantly affected in <italic>tlr2</italic> homozygous mutants was &#x0201c;neurological system process&#x0201d; (Additional&#x000a0;file&#x000a0;<xref rid="MOESM13" ref-type="media">13</xref>: Table S2). Many recent studies show that a mutation in Tlr2 in mice resulted in effects of neuronal development and responses to injury [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Some of these studies show a connection of Tlr2 deficiency to neuronal defects that could be related to Il10 function and autophagy [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. When focusing on the signaling pathways that could be involved, we observed that there was a significant effect in the GO category of transcription factors, namely the c-Maf factors that totals up to 546 representatives that were affected (Additional&#x000a0;file&#x000a0;<xref rid="MOESM14" ref-type="media">14</xref>: Table S3). The members of the Maf family of transcription factors, c-Maf and Mafb are specifically expressed in monocyte and macrophage lineages [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>], and in addition, c-Maf is also expressed in T helper cells [<xref ref-type="bibr" rid="CR67">67</xref>]. c-Maf was also reported to directly regulate IL-10 expression induced by LPS in macrophages [<xref ref-type="bibr" rid="CR68">68</xref>]. Double deficiency of Mafb/c-Maf promotes self-renewal of differentiated macrophages [<xref ref-type="bibr" rid="CR69">69</xref>]. We did not detect differences in macrophage numbers between <italic>tlr2</italic> mutants and controls, but it remains to be further investigated if macrophage differentiation is altered as a result of Tlr2 deficiency.</p><p id="Par39">Recently, we have shown that Tlr2 and its adaptor MyD88 are important for the response of the zebrafish host to the microbiome [<xref ref-type="bibr" rid="CR48">48</xref>]. Therefore, it is very well possible that the transcriptional differences we find in the <italic>tlr2</italic> mutant versus the controls are due to an aberrant response to the microbiome. Similarly, we have found that mutation in <italic>myd88</italic> leads to a large difference in the zebrafish gene expression profile, even in the absence of pathogenic infection [<xref ref-type="bibr" rid="CR48">48</xref>]. This difference appeared to be dependent on the presence of a microbiome. In future work we therefore aim to study the transcriptome response of the <italic>tlr2</italic> mutant under germfree conditions and in the presence of a microbiome under gnotobiotic conditions and investigate whether the dysregulation of neural development pathways in <italic>tlr2</italic> mutants might be linked to control of the gut-brain axis [<xref ref-type="bibr" rid="CR70">70</xref>&#x02013;<xref ref-type="bibr" rid="CR74">74</xref>]. Such studies could also show whether the composition of the microbiome affects the progression of mycobacterial infection. This could be clinically relevant, considering that recent studies show a correlation of the occurrence of tuberculosis with aberrations of the microbiome in human patients [<xref ref-type="bibr" rid="CR75">75</xref>].</p><p id="Par40">The analysis of differential gene expression during infection showed that there is a very pronounced effect of mutation of the <italic>tlr2</italic> gene. However, the expression of many genes is independent of <italic>tlr2</italic> as expected, since also other TLR receptors play a role in recognition of mycobacterial infections [<xref ref-type="bibr" rid="CR76">76</xref>&#x02013;<xref ref-type="bibr" rid="CR79">79</xref>]. With respect to the number of genes affected, the strongest effect was observed in genes that are down regulated during infection, since this category was strongly diminished in the <italic>tlr</italic>2 mutant (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a, b and Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S5). This observation suggests that Tlr2 has an important function in anti-inflammatory responses, in line with previous reports of studies in mice that showed a strongly decreased anti-inflammatory response in <italic>Tlr2</italic> knockouts [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. In a further analysis of the quantitative effects on the differences in expression levels of genes in both the up regulated and down regulated groups, we selected a number of genes that were most significantly affected in GO analysis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d, e). This GO analysis showed many groups to be affected with the immune response as the biggest group. We also performed GSEA and SNEA analyses (Additional file <xref rid="MOESM8" ref-type="media">8</xref>: Figure S8, Additional file <xref rid="MOESM9" ref-type="media">9</xref>: Figure S9, Additional&#x000a0;file&#x000a0;<xref rid="MOESM10" ref-type="media">10</xref>: Figure S10 and Additional&#x000a0;file&#x000a0;<xref rid="MOESM15" ref-type="media">15</xref>: Table S4) showing that the <italic>tlr2</italic> mutant has a very different immune response than heterozygote controls. Furthermore, we show that many signaling pathways that have been reported to be linked to tuberculosis infection in humans are differentially regulated in our data set. Most significantly, activation of the Tlr8 pathway was strongly affected (Additional&#x000a0;file&#x000a0;<xref rid="MOESM10" ref-type="media">10</xref>: Figure S10). This evidence suggests that the Tlr2 signaling is strongly connected with Tlr8 function. <italic>TLR8</italic> mutations (polymorphisms) increase susceptibility to mycobacteria in the human population [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Recently it was shown that TLR8 is a sensor of various bacteria in human primary monocytes [<xref ref-type="bibr" rid="CR81">81</xref>]. This indication that TLR8 is a more important sensor in the antibacterial defense system than previously known might explain our SNEA results. In addition, our analysis revealed differential expression of three other interesting categories of immune genes, discussed below.</p><p id="Par41">The vitamin D receptor pathway genes that are normally up-regulated during infection in zebrafish larvae were down regulated in the <italic>tlr2</italic> mutant. Furthermore, pathway analysis (Additional file <xref rid="MOESM8" ref-type="media">8</xref>: Figure S8 and Additional&#x000a0;file&#x000a0;<xref rid="MOESM10" ref-type="media">10</xref>: Figure S10) also implicated the expression of the Tlr8 pathway connected to vitamin D signaling as being strongly affected in the <italic>tlr2</italic> mutant. Vitamin D has been shown to be an important regulatory factor during tuberculosis [<xref ref-type="bibr" rid="CR82">82</xref>] and has been linked previously to TLR2 function in studies in cell cultures [<xref ref-type="bibr" rid="CR83">83</xref>]. Therefore, aberrant vitamin D signaling could be a major contributing factor to the hyper-susceptibility phenotype of <italic>tlr2</italic> mutants in Mm infection.</p><p id="Par42">Tlr2 has been shown to be essential for the up-regulation of a group of genes that encode the Diverse Immunoglobulin Domain-Containing Proteins (DICPS) (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d). This group is as novel multigene family encoding diversified immune receptors. Haire et al. [<xref ref-type="bibr" rid="CR84">84</xref>] reported that recombinant DICP Ig domains bind lipids and lipid extracts of different bacteria, including Mtb and Mm, a property shared by mammalian CD300 and TREM family members. In the down-regulated set also several DICP members appear to be dependent on Tlr2, such as <italic>dicp1.17</italic>, <italic>dicp3.3</italic>, that are linked to the GO term insulin-like growth factor binding. These correlations might relate to functions of Tlr2 in other processes such as the control of diabetes type II by gut microbiota. However, the DICP gene family lacks easily recognizable genetic homologs in mammals, making a translation to a function in mammalian tuberculosis and other diseases currently not yet possible [<xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par43">Another highly relevant category of genes of which the induction or repression during infection is dependent on Tlr2 includes the chemokines. In a previous study of our laboratory, Torraca et al. demonstrated the function of the Cxcr3-Cxcl11 axis in macrophage recruitment to infection foci and showed that disruption of this axis by <italic>cxcr3.2</italic> mutation increases the resistance to mycobacterial infection [<xref ref-type="bibr" rid="CR51">51</xref>]. Furthermore, by Fluorescence-activated cell sorting (FACS) of Mm-infected cells, we recently showed that <italic>cxcl11a</italic> is a robust marker of infected macrophages [<xref ref-type="bibr" rid="CR52">52</xref>]. The infection induced expression of this chemokine is dependent on Myd88, the common adaptor of the majority of Tlrs, including <italic>tlr2</italic> [<xref ref-type="bibr" rid="CR52">52</xref>]. In agreement, the <italic>tlr2</italic> mutant shows a significant lower expression of <italic>cxcl11aa</italic> and also of an related chemokine, <italic>cxcl11ac,</italic> during Mm infection (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Considering the large number of other chemokines that are controlled by Tlr2 during infection, it is clear that the integrative network of connections cannot yet be understood from these expression studies and need more detailed functional analyses, e.g. by combinations of different mutations or directed studies on responses to chemokines as shown by Torraca et al [<xref ref-type="bibr" rid="CR51">51</xref>]. However, we can state that the phenotype of the <italic>tlr2</italic> mutant, at the infection level, and the level of transcriptional control such as the mentioned effects on regulation of MafB/c-Maf and chemokines shows a clear connection with macrophage chemotaxis. These evidences do not exclude that Tlr2 has many other functions during infection such as phagocytosis. For instance, Blander et al. [<xref ref-type="bibr" rid="CR86">86</xref>] and Rahman et al. [<xref ref-type="bibr" rid="CR87">87</xref>] showed that phagocytosis of bacteria and phagosome maturation are impaired in the absence of TLR signaling. Therefore, the large number of unannotated genes of which the expression during infection is dependent on Tlr2 is also worth studying in more detail in future studies.</p></sec><sec id="Sec8"><title>Conclusion</title><p id="Par44">Our study shows that Tlr2, as a part of innate immunity, plays an important role in controlling mycobacterial infection as observed on the transcriptome and infection level. This function may be mediated by several mechanisms, including a general attenuation of the inflammatory response, reduced mycobacterial dissemination by dampening of CXCR3-CXCL11 signaling, and anti-mycobacterial effects like vitamin D signaling. Our results show that Tlr2 is a major Tlr family member upstream of Myd88 that activates the CXCR3-CXCL11 signaling axis. The <italic>tlr2</italic> mutant is therefore a valuable model for further studies using published infection models for other pathogens and the study of the interactions with gut microbiota in zebrafish larvae.</p></sec><sec id="Sec9"><title>Methods</title><sec id="Sec10"><title>Zebrafish husbandry</title><p id="Par45">All zebrafish were handled in compliance with the local animal welfare regulations and maintained according to standard protocols (<ext-link ext-link-type="uri" xlink:href="http://zfin.org">zfin.org</ext-link>). Larvae were raised in egg water (60&#x02009;g/ml Instant Ocean sea salts) at 28.5&#x02009;&#x000b0;C. For the duration of bacterial injections, larvae were kept under anesthesia in egg water containing 0.02% buffered 3-aminobenzoic acid ethyl ester (Tricaine, Sigma-Aldrich, the Netherlands). The culture of zebrafish with mutations in immune genes was approved by the local animal welfare committee (DEC) of the University of Leiden (protocol 14,198). All protocols adhered to the international guidelines specified by the EU Animal Protection Directive 2010/63/EU.</p><p id="Par46">The <italic>tlr2</italic><sup>sa19423</sup> mutant line (ENU-mutagenized) was obtained from the Sanger Institute Zebrafish Mutation Resource (Hinxton, Cambridge, UK) and shipped by the Zebrafish Resource Center of the Karlsruhe Institute of Technology. The mutant allele was identified by sequencing. Heterozygous carriers of the mutation were outcrossed three times against wild type (<italic>AB</italic> strain), and were subsequently incrossed three times. Heterozygous fish of the resulting family were used to produce embryos. Homozygous mutants were outcrossed to the <italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> double transgenic line [<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR89">89</xref>], and the offspring with GFP and mCherry fluorescence were subsequently incrossed to produce the <italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> line.</p></sec><sec id="Sec11"><title>Bacterial strain preparation</title><p id="Par47">The bacterial strain, <italic>Mycobacterium marinum</italic> m20 (Mma20) expressing mCherry fluorescent protein [<xref ref-type="bibr" rid="CR90">90</xref>], was used in this study. For the infection to zebrafish larvae, the bacteria were prepared as previously described [<xref ref-type="bibr" rid="CR91">91</xref>]. The infection inoculum was prepared in 2% polyvinylpyrrolidone40 solution (Calbiochem, the Netherlands), and 150 colony-forming units (CFU) of bacteria were injected into the blood stream at 28&#x02009;h post fertilization (hpf) as previously described [<xref ref-type="bibr" rid="CR92">92</xref>].</p></sec><sec id="Sec12"><title>Ligands injection</title><p id="Par48">Purified Pam3CSK4 (InvivoGen, France) and flagellin from <italic>S. typhimurium</italic> (Flagellin FliC VacciGrade&#x02122;, Invitrogen, France) were diluted in 1&#x02009;mg/ml and 100&#x02009;&#x003bc;g/ml in sterile water, respectively. For injection, 1&#x02009;nl of the ligand solutions were injected into the blood stream at 28hpf. Sterile water was injected as a control experiment. Injections were performed using a FemtoJet microinjector (Eppendorf, the Netherlands) equipped with a capillary glass needle.</p></sec><sec id="Sec13"><title>Bacterial burden imaging and quantification</title><p id="Par49">Pools of 20 larvae were collected at 3- and 4-day post infection (dpi) and imaged by using the Leica MZ16FA Fluorescence Stereo Microscope (Leica Microsystems, Wetzlar Germany) equipped with the DFC420C color camera (Leica Microsystems). Bacterial loads were analyzed using dedicated pixel counting software as previously described [<xref ref-type="bibr" rid="CR93">93</xref>].</p></sec><sec id="Sec14"><title>Confocal laser scanning microscopy imaging and image quantification</title><p id="Par50">Larvae (2 dpf) were embedded in 1% low melting point agarose (Sigma Aldrich), and image acquisition was performed by using a Leica TCS SP8 confocal microscope (Leica Microsystems) with a 10 times magnification objective (N.A. 0.40). Acquisition settings and area of imaging (in the caudal vein region) were kept the same across the groups for macrophages and neutrophils number counting (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> j, k) and pixel counting (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). Experiments were performed in two independent series. Double fluorescent lines <italic>tlr2</italic><sup><italic>+/+</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> were used for macrophages and neutrophils number counting. Macrophage and neutrophil cell counting was either performed manually or by using the plugin Find Maxima in Fiji (<ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/docs/menus/">http://imagej.nih.gov/ij/docs/menus/</ext-link> process.html#find-maxima) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> j, k) using projections of the z-series. 25 individual larvae for each group were used for counting and representative images are given in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>h, i. With manual counting the z-series data was examined in cases when it was unclear whether the fluorescent pixels presented one or multiple cells. The result of manual cell counting (Additional&#x000a0;file&#x000a0;<xref rid="MOESM11" ref-type="media">11</xref>: Figure S11) is comparable with the result of automated cell counting using Fiji. Pixel counting of the double transgenic lines (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1 a, b) was performed using dedicated pixel counting software as well as previously described [<xref ref-type="bibr" rid="CR93">93</xref>]. For CLSM analysis of progression of infection of Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> we used Fiji software. To quantify the number of bacteria outside macrophages, total bacteria pixel count was quantified by Fiji software and followed by subtracting this number with the number of co-localised pixels. Co-localisation of macrophage and bacterial pixels was performed using a custom made script written in Java. For this experiment we used three objectives: 10x (N.A. 0.40), 20x (N.A. 0.75), 63x (oil immersion, N.A. 1.40) magnification.</p></sec><sec id="Sec15"><title>RNA isolation, cDNA synthesis and qPCR</title><p id="Par51">Total RNAs were extracted using TRIzol Reagent (Life Technologies) and purified using RNeasy MinElute Cleanup Kit (Qiagen, the Netherlands). The concentration and quality of RNAs were evaluated by NanoDrop 2000 (Thermo Scientific, the Netherlands). cDNAs were synthesized from 1&#x02009;&#x003bc;g total RNAs and qPCR were performed by using the iScript&#x02122; cDNA Synthesis Kit (BioRad, the Netherlands) and iQ&#x02122; SYBR Green Supermix (BioRad) and normalized against the expression of <italic>ppial</italic> as a housekeeping gene [<xref ref-type="bibr" rid="CR94">94</xref>]. Results were analyzed using the &#x00394;&#x00394;Ct method [<xref ref-type="bibr" rid="CR95">95</xref>]. Primer sequences are described in Additional&#x000a0;file&#x000a0;<xref rid="MOESM16" ref-type="media">16</xref>: Table S5.</p></sec><sec id="Sec16"><title>Deep sequencing and data analysis</title><p id="Par52">Triplicates of 10 larvae of <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> with PBS (as control) or Mma20 injection, were homogenized in 300ul of TRIzol reagent, and total RNAs were purified as described above. RNAseq was performed using Illumina Hi-Seq 2500 as previously described [<xref ref-type="bibr" rid="CR96">96</xref>]. The raw data is available in the NCBI GEO database under accession number GSE102766. The RNAseq data were mapped on the zebrafish genome (version GRCz10) and tag counts were performed by Bowtie 2 using GeneTiles software (<ext-link ext-link-type="uri" xlink:href="http://www.genetiles.com">http://www.genetiles.com</ext-link>) [<xref ref-type="bibr" rid="CR97">97</xref>]. Then, we performed normalization and gene expression analysis using the R package and DESeq2 [<xref ref-type="bibr" rid="CR98">98</xref>]. After statistical tests, we performed further bioinformatics analyses Gene-Set Enrichment Analysis [<xref ref-type="bibr" rid="CR54">54</xref>], Sub-Network Enrichment Analysis [<xref ref-type="bibr" rid="CR55">55</xref>] and Pathway Enrichment Analysis [<xref ref-type="bibr" rid="CR99">99</xref>]. For creating gene networks based on common regulatory targets, we used Pathway Studio 9.0 (Elsevier, Amsterdam, the Netherlands) as previously described [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par53">Comparison of edgeR and DEseq2: EdgeR and DEseq2 differ mainly in the aspects of normalization and estimation of the dispersion parameters. Normalization in edgeR is done via the trimmed mean of M values, while in DEseq2 this is done by comparing each library with a virtual library based on the relative log expressions. The dispersion parameters in edgeR are estimated by empirical Bayes and are therefore shrunken towards the overall mean of the estimates. Dispersion in DEseq2 is estimated by taking the maximum of the individual dispersions and the mean trend of the dispersions. As a consequence, edgeR tends to be more sensitive to outliers, while DEseq2 is less powerful [<xref ref-type="bibr" rid="CR49">49</xref>].</p></sec><sec id="Sec17"><title>Statistical analyses</title><p id="Par54">Graphpad Prism software (Version 8.1.1; GraphPad Software, San Diego, CA, USA) was used for statistical analysis. All experiment data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. In the gene expression profiles of zebrafish treated with the TLR2 agonist (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> b-g) and in immune gene expression in <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> fish lines infected with Mm (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>), statistical significance of differences was determined by two-way ANOVA with Tukey&#x02019;s Multiple Comparison test as a post-hoc test. The other experiments were analyzed by using unpaired, two-tailed t-tests for comparisons between two groups and one-way ANOVA with Tukey&#x02019;s multiple comparison methods as a post-hoc test for comparisons between more than two groups. For percent survival analysis (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> f), statistical significance of difference was determined by a log-rank (Mantel-Cox) test. (ns, no significant difference; *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; ****<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001).</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12864_2019_6265_MOESM1_ESM.tif"><caption><p><bold>Additional file 1: </bold>
<bold>Figure S1.</bold> Pixel count analysis for double transgenic lines <italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> of 2 dpf <italic>tlr2</italic><sup>+/+</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> embryos. a: mCherry reporter, b, EGFP reporter.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12864_2019_6265_MOESM2_ESM.tif"><caption><p><bold>Additional file 2: </bold>
<bold>Figure S2.</bold> RNAseq read counts of <italic>tlr2</italic> transcripts in heterozygotes (<italic>tlr2</italic><sup><italic>+/</italic>&#x02212;</sup>) control versus <italic>tlr2</italic> mutant (<italic>tlr2</italic><sup><italic>&#x02212;/</italic>&#x02212;</sup>) larvae. RNAseq data comparing reads mapped to <italic>tlr2</italic> transcript (ENSDART0000012256). Heterozygotes and mutant reads are mapped to the entire length of the mutant transcript indicating that the mutant transcript is not subjected to nonsense mediated decay. Mutant data (MEAS) and heterozygotes (CTRL) data have been submitted to the NCBI gene expression Omnibus database, accession number is GSE102766.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="12864_2019_6265_MOESM3_ESM.tif"><caption><p><bold>Additional file 3: </bold>
<bold>Figure S3.</bold> Analysis of differential expression of genes functioning in glycolysis and gluconeogenesis between uninfected <italic>tlr2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>tlr2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>. The red boxes represent up regulated genes (FC &#x0003e;&#x02009;2); blue boxes represent down regulated genes (FC&#x02009;&#x0003c;&#x02009;-2); yellow boxes represent the genes that are differentially expressed with a <italic>P</italic> value lower than 0.05; green represent not-significantly differentially expressed genes.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="12864_2019_6265_MOESM4_ESM.tif"><caption><p><bold>Additional file 4: </bold>
<bold>Figure S4.</bold> Representative images of the quantification of Mma20 infection phenotype in the <italic>tlr2</italic> mutant, heterozygote and wild type siblings. One representative picture is shown for the entire sets of 38, 47 and 37 larvae were analysed for the <italic>tlr2</italic> mutant, the heterozygote and the wild-type, respectively. Macrophages are in green and bacteria are in red. The scale bar represents 50&#x02009;&#x003bc;m.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="12864_2019_6265_MOESM5_ESM.tif"><caption><p><bold>Additional file 5: </bold>
<bold>Figure S5.</bold> Volcano plots showing the significance cutoff applied to <italic>tlr2</italic><sup>+/&#x02212;</sup> infected with strain Mma20 versus control with PBS (a) and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> infected with strain Mma20 versus control with PBS (b). In these volcano plots, the transcripts were considered significant (red) or non-significant (blue) by the conditions of |fold change| &#x02265;&#x02009;1,45 and adjusted <italic>P</italic> value threshold&#x02009;&#x02264;&#x02009;0,05. Fold changes for each transcript was plotted on the X-axis against -log10 transformed <italic>p</italic>-values on the Y-axis.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="12864_2019_6265_MOESM6_ESM.tif"><caption><p><bold>Additional file 6: </bold>
<bold>Figure S6.</bold>
<italic>tlr2</italic>-dependent up regulation of genes with various GO terms.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="12864_2019_6265_MOESM7_ESM.tif"><caption><p><bold>Additional file 7: </bold>
<bold>Figure S7.</bold>
<italic>tlr2</italic>-dependent down regulation of genes with various GO terms.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="12864_2019_6265_MOESM8_ESM.zip"><caption><p><bold>Additional file 8: </bold>
<bold>Figure S8.</bold> Sub-network enrichment analysis. Networks of common targets of the 97 up regulated genes (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>d) in <italic>tlr2</italic><sup>+/&#x02212;</sup> (a) and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> (b) with Mma20 infection. Red represents up regulation, blue represents down regulation and grey represents genes for which no expression was detected.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="12864_2019_6265_MOESM9_ESM.tif"><caption><p><bold>Additional file 9: </bold>
<bold>Figure S9.</bold> Sub-network enrichment analysis. The networks of common targets of the 92 down regulated genes (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>e) in <italic>tlr2</italic><sup>+/&#x02212;</sup> (a) and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> (b) with Mma20 infection. Red represents up-regulation, blue represents down-regulation and grey represents genes for which no expression was detected.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="12864_2019_6265_MOESM10_ESM.tif"><caption><p><bold>Additional file 10: </bold>
<bold>Figure S10.</bold> Sub-network enrichment analysis between zebrafish and human. The Tlr8 pathway in zebrafish (a) with Mm infection and human macrophages (b) with Mtb infection. Red represents up-regulation, blue represents down-regulation.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="12864_2019_6265_MOESM11_ESM.tif"><caption><p><bold>Additional file 11: </bold>
<bold>Figure S11.</bold> Manual counting analysis for <italic>Tg</italic> (<italic>mpeg1:mCherry-F);TgBAC (mpx: EGFP)</italic> of neutrophils (a) and macrophages (b) in 2 dpf <italic>tlr2</italic><sup>+/+</sup> and <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> embryos.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM12"><media xlink:href="12864_2019_6265_MOESM12_ESM.xlsx"><caption><p><bold>Additional file 12: </bold>
<bold>Table S1.</bold> Reads of <italic>mpeg1.1</italic> and <italic>mpx</italic> genes of the <italic>tlr2</italic><sup>+/&#x02212;</sup> control and the <italic>tlr2</italic><sup>&#x02212;/&#x02212;</sup> mutant in RNAseq analysis.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM13"><media xlink:href="12864_2019_6265_MOESM13_ESM.xlsx"><caption><p><bold>Additional file 13: </bold>
<bold>Table S2.</bold> GO analysis of genes that have a different basal expression level in the absence of infection in the Tlr2 mutant versus the heterozygote control. Shown is the GO analysis of the group of 878 genes that were different with a FDR <italic>P</italic> value of 10<sup>&#x02212;&#x02009;10</sup> indicated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM14"><media xlink:href="12864_2019_6265_MOESM14_ESM.xlsx"><caption><p><bold>Additional file 14: </bold>
<bold>Table S3.</bold> Two categories of genes including the c-Maf transcription factor were significantly affected in the GO category.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM15"><media xlink:href="12864_2019_6265_MOESM15_ESM.xlsx"><caption><p><bold>Additional file 15: </bold>
<bold>Table S4.</bold> A-H Gene lists of GSEA and SNEA analysis.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM16"><media xlink:href="12864_2019_6265_MOESM16_ESM.xlsx"><caption><p><bold>Additional file 16: </bold>
<bold>Table S5.</bold> List of primers.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CFU</term><def><p id="Par4">Colony-forming units</p></def></def-item><def-item><term>CLSM</term><def><p id="Par5">Confocal laser scanning microscopy</p></def></def-item><def-item><term>DEGs</term><def><p id="Par6">Differential expressed genes</p></def></def-item><def-item><term>Dpf</term><def><p id="Par7">Days post fertilization</p></def></def-item><def-item><term>Dpi</term><def><p id="Par8">Days post injection</p></def></def-item><def-item><term>FACS</term><def><p id="Par9">Fluorescence-activated cell sorting</p></def></def-item><def-item><term>FDR</term><def><p id="Par10">False discovery rate</p></def></def-item><def-item><term>GSEA</term><def><p id="Par11">Gene-Set Enrichment Analysis</p></def></def-item><def-item><term>Hpf</term><def><p id="Par12">Hours post fertilization</p></def></def-item><def-item><term>Hpi</term><def><p id="Par13">Hours post injection</p></def></def-item><def-item><term>Mm</term><def><p id="Par14">
<italic>Mycobacterium marinum</italic>
</p></def></def-item><def-item><term>Mtb</term><def><p id="Par15">
<italic>Mycobacterium tuberculosis</italic>
</p></def></def-item><def-item><term>NMD</term><def><p id="Par16">Non-sense mediated mRNA decay</p></def></def-item><def-item><term>qPCR</term><def><p id="Par17">Quantitative polymerase chain reaction</p></def></def-item><def-item><term>RNAseq</term><def><p id="Par18">Deep sequencing of cDNA derived from polyA RNA</p></def></def-item><def-item><term>SNEA</term><def><p id="Par19">Sub-Network Enrichment Analysis</p></def></def-item><def-item><term>TB</term><def><p id="Par20">Tuberculosis</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Wanbin Hu and Shuxin Yang contributed equally to this work.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12864-019-6265-1.</p></sec><ack><p>We thank all members of the fish facility team for fish caretaking. We would like to thank our colleagues from Leiden University: Lanpeng Chen and Gerda E.M. Lamers for assistance with confocal laser scanning imaging and Joost J. Willemse for providing microscopic analysis programs. We also thank Vincenzo Torraca (London School of Hygiene &#x00026; Tropical Medicine) for helpful discussions and the qPCR primers of <italic>cxcl11-</italic>like genes. The zebrafish <italic>tlr2</italic> mutant was obtained from the Sanger Institute Zebrafish Mutation Resource (ZF-MODELS Integrated Project funded by the European Commission; contract number LSHG-CT-2003-503496), also sponsored by the Welcome Trust [grant number WT 077047/Z/05/Z].</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>SY and WH carried out all the experimental operations. SY, YS, and HPS performed RNAseq data analysis. SY, WH and HPS wrote the first draft of the manuscript. SY, WH and HPS participated in the design of the study and coordination. AHM and RMJ helped to revise the final manuscript. HPS conceived the study. MM assisted in statistical analysis of RNAseq data. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>S. Y. and W. H were supported by grants from the China Scholarship Council (CSC). This funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The raw data of the RNAseq experiments is available in the NCBI GEO database under accession number GSE102766.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par55">No animals were used for experimentation. Larvae for experiments were obtained from zebrafish lines that were handled in compliance with the local animal welfare regulations and maintained according to standard protocols (<ext-link ext-link-type="uri" xlink:href="http://zfin.org">zfin.org</ext-link>). The breeding of adult fish was approved by the local animal welfare committee (DEC) of the University of Leiden. All protocols adhered to the international guidelines specified by the EU Animal Protection Directive 2010/63/EU for which larvae under the age of 5&#x02009;days post fertilization are not considered test animals.</p></notes><notes><title>Consent for publication</title><p id="Par56">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par57">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>The zebrafish guide to tuberculosis immunity and treatment</article-title><source>Cold Spring Harbor Symp Quant Biol</source><year>2013</year><volume>78</volume><fpage>179</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1101/sqb.2013.78.023283</pub-id><pub-id pub-id-type="pmid">24643219</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Co</surname><given-names>DO</given-names></name><name><surname>Hogan</surname><given-names>LH</given-names></name><name><surname>Kim</surname><given-names>SI</given-names></name><name><surname>Sandor</surname><given-names>M</given-names></name></person-group><article-title>Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship</article-title><source>Clin Immunol</source><year>2004</year><volume>113</volume><issue>2</issue><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2004.08.012</pub-id><pub-id pub-id-type="pmid">15451467</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgame</surname><given-names>P</given-names></name></person-group><article-title>Host innate and Th1 responses and the bacterial factors that control <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Curr Opin Immunol</source><year>2005</year><volume>17</volume><issue>4</issue><fpage>374</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2005.06.006</pub-id><pub-id pub-id-type="pmid">15963709</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>Revisiting the role of the granuloma in tuberculosis</article-title><source>Nat Rev Immunol</source><year>2012</year><volume>12</volume><issue>5</issue><fpage>352</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1038/nri3211</pub-id><pub-id pub-id-type="pmid">22517424</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>EK</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Choi</surname><given-names>CH</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name></person-group><article-title>Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors</article-title><source>Cell Microbiol</source><year>2007</year><volume>9</volume><issue>5</issue><fpage>1087</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00914.x</pub-id><pub-id pub-id-type="pmid">17359235</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapping</surname><given-names>RI</given-names></name><name><surname>Tobias</surname><given-names>PS</given-names></name></person-group><article-title>Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling</article-title><source>J Endotoxin Res</source><year>2003</year><volume>9</volume><issue>4</issue><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1177/09680519030090040801</pub-id><pub-id pub-id-type="pmid">12935358</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Means</surname><given-names>TK</given-names></name><name><surname>Jones</surname><given-names>BW</given-names></name><name><surname>Schromm</surname><given-names>AB</given-names></name><name><surname>Shurtleff</surname><given-names>BA</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Golenbock</surname><given-names>DT</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name></person-group><article-title>Differential effects of a Toll-like receptor antagonist on <italic>Mycobacterium tuberculosis</italic>-induced macrophage responses</article-title><source>J Immunol</source><year>2001</year><volume>166</volume><issue>6</issue><fpage>4074</fpage><lpage>4082</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.6.4074</pub-id><pub-id pub-id-type="pmid">11238656</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quesniaux</surname><given-names>VJ</given-names></name><name><surname>Nicolle</surname><given-names>DM</given-names></name><name><surname>Torres</surname><given-names>D</given-names></name><name><surname>Kremer</surname><given-names>L</given-names></name><name><surname>Guerardel</surname><given-names>Y</given-names></name><name><surname>Nigou</surname><given-names>J</given-names></name><name><surname>Puzo</surname><given-names>G</given-names></name><name><surname>Erard</surname><given-names>F</given-names></name><name><surname>Ryffel</surname><given-names>B</given-names></name></person-group><article-title>Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><issue>7</issue><fpage>4425</fpage><lpage>4434</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.7.4425</pub-id><pub-id pub-id-type="pmid">15034058</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>SB</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Shin</surname><given-names>AR</given-names></name><name><surname>Jung</surname><given-names>SS</given-names></name><name><surname>Son</surname><given-names>JW</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Paik</surname><given-names>TH</given-names></name><etal/></person-group><article-title>The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><issue>5</issue><fpage>2686</fpage><lpage>2696</lpage><pub-id pub-id-type="doi">10.1128/IAI.74.5.2686-2696.2006</pub-id><?supplied-pmid 1459749?><pub-id pub-id-type="pmid">16622205</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brightbill</surname><given-names>HD</given-names></name><name><surname>Libraty</surname><given-names>DH</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Yang</surname><given-names>RB</given-names></name><name><surname>Belisle</surname><given-names>JT</given-names></name><name><surname>Bleharski</surname><given-names>JR</given-names></name><name><surname>Maitland</surname><given-names>M</given-names></name><name><surname>Norgard</surname><given-names>MV</given-names></name><name><surname>Plevy</surname><given-names>SE</given-names></name><name><surname>Smale</surname><given-names>ST</given-names></name><etal/></person-group><article-title>Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors</article-title><source>Science</source><year>1999</year><volume>285</volume><issue>5428</issue><fpage>732</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1126/science.285.5428.732</pub-id><pub-id pub-id-type="pmid">10426995</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noss</surname><given-names>EH</given-names></name><name><surname>Pai</surname><given-names>RK</given-names></name><name><surname>Sellati</surname><given-names>TJ</given-names></name><name><surname>Radolf</surname><given-names>JD</given-names></name><name><surname>Belisle</surname><given-names>J</given-names></name><name><surname>Golenbock</surname><given-names>DT</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name></person-group><article-title>Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of <italic>Mycobacterium tuberculosis</italic></article-title><source>J Immunol</source><year>2001</year><volume>167</volume><issue>2</issue><fpage>910</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.2.910</pub-id><pub-id pub-id-type="pmid">11441098</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilleron</surname><given-names>M</given-names></name><name><surname>Quesniaux</surname><given-names>VF</given-names></name><name><surname>Puzo</surname><given-names>G</given-names></name></person-group><article-title>Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and <italic>Mycobacterium tuberculosis</italic> H37Rv and its implication in Toll-like receptor response</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>32</issue><fpage>29880</fpage><lpage>29889</lpage><pub-id pub-id-type="doi">10.1074/jbc.M303446200</pub-id><pub-id pub-id-type="pmid">12775723</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilleron</surname><given-names>M</given-names></name><name><surname>Nigou</surname><given-names>J</given-names></name><name><surname>Nicolle</surname><given-names>D</given-names></name><name><surname>Quesniaux</surname><given-names>V</given-names></name><name><surname>Puzo</surname><given-names>G</given-names></name></person-group><article-title>The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2</article-title><source>Chem Biol</source><year>2006</year><volume>13</volume><issue>1</issue><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2005.10.013</pub-id><pub-id pub-id-type="pmid">16426970</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Horiuchi</surname><given-names>T</given-names></name><name><surname>Hoshino</surname><given-names>K</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><issue>1</issue><fpage>10</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.1.10</pub-id><pub-id pub-id-type="pmid">12077222</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>M&#x000fc;hlradt</surname><given-names>PF</given-names></name><name><surname>Morr</surname><given-names>M</given-names></name><name><surname>Radolf</surname><given-names>JD</given-names></name><name><surname>Zychlinsky</surname><given-names>A</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>Discrimination of bacterial lipoproteins by Toll-like receptor 6</article-title><source>Int Immunol</source><year>2001</year><volume>13</volume><issue>7</issue><fpage>933</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1093/intimm/13.7.933</pub-id><pub-id pub-id-type="pmid">11431423</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinho</surname><given-names>FAV</given-names></name><name><surname>de Paula</surname><given-names>RR</given-names></name><name><surname>Mendes</surname><given-names>AC</given-names></name><name><surname>de Almeida</surname><given-names>LA</given-names></name><name><surname>Gomes</surname><given-names>MTR</given-names></name><name><surname>Carvalho</surname><given-names>NB</given-names></name><name><surname>Oliveira</surname><given-names>FS</given-names></name><name><surname>Caliari</surname><given-names>MV</given-names></name><name><surname>Oliveira</surname><given-names>SC</given-names></name></person-group><article-title>Toll-like receptor 6 senses <italic>Mycobacterium avium</italic> and is required for efficient control of mycobacterial infection</article-title><source>Eur J Immunol</source><year>2013</year><volume>43</volume><issue>9</issue><fpage>2373</fpage><lpage>2385</lpage><pub-id pub-id-type="doi">10.1002/eji.201243208</pub-id><pub-id pub-id-type="pmid">23716075</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Jo</surname><given-names>EK</given-names></name></person-group><article-title>Mycobacterial signaling through toll-like receptors</article-title><source>Front Cell Infect Microbiol</source><year>2012</year><volume>2</volume><fpage>145</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2012.00145</pub-id><?supplied-pmid 3504976?><pub-id pub-id-type="pmid">23189273</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underhill</surname><given-names>DM</given-names></name><name><surname>Ozinsky</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>KD</given-names></name><name><surname>Aderem</surname><given-names>A</given-names></name></person-group><article-title>Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><issue>25</issue><fpage>14459</fpage><lpage>14463</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.25.14459</pub-id><?supplied-pmid 24458?><pub-id pub-id-type="pmid">10588727</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlos</surname><given-names>D</given-names></name><name><surname>Frantz</surname><given-names>FG</given-names></name><name><surname>Souza-Junior</surname><given-names>DA</given-names></name><name><surname>Jamur</surname><given-names>MC</given-names></name><name><surname>Oliver</surname><given-names>C</given-names></name><name><surname>Ramos</surname><given-names>SG</given-names></name><name><surname>Quesniaux</surname><given-names>VF</given-names></name><name><surname>Ryffel</surname><given-names>B</given-names></name><name><surname>Silva</surname><given-names>CL</given-names></name><name><surname>Bozza</surname><given-names>MT</given-names></name><etal/></person-group><article-title>TLR2-dependent mast cell activation contributes to the control of <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Microbes Infect</source><year>2009</year><volume>11</volume><issue>8&#x02013;9</issue><fpage>770</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2009.04.025</pub-id><pub-id pub-id-type="pmid">19442756</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiling</surname><given-names>N</given-names></name><name><surname>Holscher</surname><given-names>C</given-names></name><name><surname>Fehrenbach</surname><given-names>A</given-names></name><name><surname>Kroger</surname><given-names>S</given-names></name><name><surname>Kirschning</surname><given-names>CJ</given-names></name><name><surname>Goyert</surname><given-names>S</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name></person-group><article-title>Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J Immunol</source><year>2002</year><volume>169</volume><issue>7</issue><fpage>3480</fpage><lpage>3484</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.7.3480</pub-id><pub-id pub-id-type="pmid">12244136</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drennan</surname><given-names>MB</given-names></name><name><surname>Nicolle</surname><given-names>D</given-names></name><name><surname>Quesniaux</surname><given-names>VJ</given-names></name><name><surname>Jacobs</surname><given-names>M</given-names></name><name><surname>Allie</surname><given-names>N</given-names></name><name><surname>Mpagi</surname><given-names>J</given-names></name><name><surname>Fremond</surname><given-names>C</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Kirschning</surname><given-names>C</given-names></name><name><surname>Ryffel</surname><given-names>B</given-names></name></person-group><article-title>Toll-like receptor 2-deficient mice succumb to <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Am J Pathol</source><year>2004</year><volume>164</volume><issue>1</issue><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)63095-7</pub-id><?supplied-pmid 1602241?><pub-id pub-id-type="pmid">14695318</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>A</given-names></name><name><surname>Konowich</surname><given-names>J</given-names></name><name><surname>Salgame</surname><given-names>P</given-names></name></person-group><article-title>Host defense and recruitment of Foxp3(+) T regulatory cells to the lungs in chronic <italic>Mycobacterium tuberculosis</italic> infection requires toll-like receptor 2</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><issue>6</issue><fpage>e1003397</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003397</pub-id><?supplied-pmid 3681744?><pub-id pub-id-type="pmid">23785280</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogus</surname><given-names>AC</given-names></name><name><surname>Yoldas</surname><given-names>B</given-names></name><name><surname>Ozdemir</surname><given-names>T</given-names></name><name><surname>Uguz</surname><given-names>A</given-names></name><name><surname>Olcen</surname><given-names>S</given-names></name><name><surname>Keser</surname><given-names>I</given-names></name><name><surname>Coskun</surname><given-names>M</given-names></name><name><surname>Cilli</surname><given-names>A</given-names></name><name><surname>Yegin</surname><given-names>O</given-names></name></person-group><article-title>The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease</article-title><source>Eur Respir J</source><year>2004</year><volume>23</volume><issue>2</issue><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1183/09031936.03.00061703</pub-id><pub-id pub-id-type="pmid">14979495</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>D</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Sindhwani</surname><given-names>G</given-names></name><name><surname>Patras</surname><given-names>A</given-names></name></person-group><article-title>TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients</article-title><source>BMC Res Notes</source><year>2009</year><volume>2</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.1186/1756-0500-2-162</pub-id><?supplied-pmid 2732632?><pub-id pub-id-type="pmid">19686607</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehring</surname><given-names>AJ</given-names></name><name><surname>Dobos</surname><given-names>KM</given-names></name><name><surname>Belisle</surname><given-names>JT</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><issue>4</issue><fpage>2660</fpage><lpage>2668</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.4.2660</pub-id><pub-id pub-id-type="pmid">15294983</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraav</surname><given-names>I</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><article-title>Outcome of <italic>Mycobacterium tuberculosis</italic> and Toll-like receptor interaction: immune response or immune evasion?</article-title><source>Immunol Cell Biol</source><year>2014</year><volume>92</volume><issue>9</issue><fpage>741</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1038/icb.2014.52</pub-id><pub-id pub-id-type="pmid">24983458</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Van der Meer</surname><given-names>JW</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><article-title>Toll-like receptors as an escape mechanism from the host defense</article-title><source>Trends Microbiol</source><year>2004</year><volume>12</volume><issue>11</issue><fpage>484</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2004.09.004</pub-id><pub-id pub-id-type="pmid">15488388</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noss</surname><given-names>EH</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> inhibits MHC class II antigen processing in murine bone marrow macrophages</article-title><source>Cell Immunol</source><year>2000</year><volume>201</volume><issue>1</issue><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1006/cimm.2000.1633</pub-id><pub-id pub-id-type="pmid">10805975</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Sutmuller</surname><given-names>R</given-names></name><name><surname>Hermann</surname><given-names>C</given-names></name><name><surname>Van der Graaf</surname><given-names>CA</given-names></name><name><surname>Van der Meer</surname><given-names>JW</given-names></name><name><surname>van Krieken</surname><given-names>JH</given-names></name><name><surname>Hartung</surname><given-names>T</given-names></name><name><surname>Adema</surname><given-names>G</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><article-title>Toll-like receptor 2 suppresses immunity against <italic>Candida albicans</italic> through induction of IL-10 and regulatory T cells</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><issue>6</issue><fpage>3712</fpage><lpage>3718</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.6.3712</pub-id><pub-id pub-id-type="pmid">15004175</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sing</surname><given-names>A</given-names></name><name><surname>Rost</surname><given-names>D</given-names></name><name><surname>Tvardovskaia</surname><given-names>N</given-names></name><name><surname>Roggenkamp</surname><given-names>A</given-names></name><name><surname>Wiedemann</surname><given-names>A</given-names></name><name><surname>Kirschning</surname><given-names>CJ</given-names></name><name><surname>Aepfelbacher</surname><given-names>M</given-names></name><name><surname>Heesemann</surname><given-names>J</given-names></name></person-group><article-title>Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression</article-title><source>J Exp Med</source><year>2002</year><volume>196</volume><issue>8</issue><fpage>1017</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1084/jem.20020908</pub-id><?supplied-pmid 2194041?><pub-id pub-id-type="pmid">12391013</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehring</surname><given-names>AJ</given-names></name><name><surname>Rojas</surname><given-names>RE</given-names></name><name><surname>Canaday</surname><given-names>DH</given-names></name><name><surname>Lakey</surname><given-names>DL</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group><article-title>The <italic>Mycobacterium tuberculosis</italic> 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><issue>8</issue><fpage>4487</fpage><lpage>4497</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.8.4487-4497.2003</pub-id><?supplied-pmid 12874328?><pub-id pub-id-type="pmid">12874328</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>GR</given-names></name><name><surname>Zwilling</surname><given-names>BS</given-names></name><name><surname>Lafuse</surname><given-names>WP</given-names></name></person-group><article-title><italic>Mycobacterium avium</italic> inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA stabilization</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><issue>12</issue><fpage>6766</fpage><lpage>6773</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.12.6766</pub-id><pub-id pub-id-type="pmid">14662881</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Doughty</surname><given-names>B</given-names></name><name><surname>Gerwitz</surname><given-names>A</given-names></name><name><surname>Blenis</surname><given-names>J</given-names></name><name><surname>Van Dyke</surname><given-names>T</given-names></name><name><surname>Pulendran</surname><given-names>B</given-names></name></person-group><article-title>Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><issue>10</issue><fpage>4984</fpage><lpage>4989</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.10.4984</pub-id><?supplied-pmid 14607893?><pub-id pub-id-type="pmid">14607893</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>SH</given-names></name><name><surname>Chua</surname><given-names>HL</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Lam</surname><given-names>TJ</given-names></name><name><surname>Sin</surname><given-names>YM</given-names></name></person-group><article-title>Development and maturation of the immune system in zebrafish, <italic>Danio rerio</italic>: a gene expression profiling, in situ hybridization and immunological study</article-title><source>Dev Comp Immunol</source><year>2004</year><volume>28</volume><issue>1</issue><fpage>9</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/S0145-305X(03)00103-4</pub-id><pub-id pub-id-type="pmid">12962979</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willett</surname><given-names>CE</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Zuasti</surname><given-names>A</given-names></name><name><surname>Zapata</surname><given-names>AG</given-names></name></person-group><article-title>Early hematopoiesis and developing lymphoid organs in the zebrafish</article-title><source>Dev Dyn</source><year>1999</year><volume>214</volume><issue>4</issue><fpage>323</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199904)214:4&#x0003c;323::AID-AJA5&#x0003e;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">10213388</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaim</surname><given-names>LE</given-names></name><name><surname>Connolly</surname><given-names>LE</given-names></name><name><surname>Volkman</surname><given-names>HE</given-names></name><name><surname>Humbert</surname><given-names>O</given-names></name><name><surname>Born</surname><given-names>DE</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title><italic>Mycobacterium marinum</italic> Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><issue>11</issue><fpage>6108</fpage><lpage>6117</lpage><pub-id pub-id-type="doi">10.1128/IAI.00887-06</pub-id><?supplied-pmid 17057088?><pub-id pub-id-type="pmid">17057088</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Clay</surname><given-names>H</given-names></name><name><surname>Lewis</surname><given-names>JL</given-names></name><name><surname>Ghori</surname><given-names>N</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos</article-title><source>Immunity</source><year>2002</year><volume>17</volume><issue>6</issue><fpage>693</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00475-2</pub-id><pub-id pub-id-type="pmid">12479816</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Protection and pathology in TB: learning from the zebrafish model</article-title><source>Semin Immunopathol</source><year>2016</year><volume>38</volume><issue>2</issue><fpage>261</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/s00281-015-0522-4</pub-id><pub-id pub-id-type="pmid">26324465</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronan</surname><given-names>MR</given-names></name><name><surname>Tobin</surname><given-names>DM</given-names></name></person-group><article-title>Fit for consumption: zebrafish as a model for tuberculosis</article-title><source>Dis Models Mech</source><year>2014</year><volume>7</volume><issue>7</issue><fpage>777</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1242/dmm.016089</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesley</surname><given-names>R</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>Insights into early mycobacterial pathogenesis from the zebrafish</article-title><source>Curr Opin Microbiol</source><year>2008</year><volume>11</volume><issue>3</issue><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2008.05.013</pub-id><?supplied-pmid 3071758?><pub-id pub-id-type="pmid">18571973</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>G</given-names></name><name><surname>Misra</surname><given-names>R</given-names></name><name><surname>Sajid</surname><given-names>A</given-names></name></person-group><article-title>Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis</article-title><source>Curr Top Med Chem</source><year>2017</year><volume>17</volume><issue>18</issue><fpage>2077</fpage><lpage>2099</lpage><pub-id pub-id-type="doi">10.2174/1568026617666170130111324</pub-id><pub-id pub-id-type="pmid">28137237</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanwal</surname><given-names>Z</given-names></name><name><surname>Wiegertjes</surname><given-names>GF</given-names></name><name><surname>Veneman</surname><given-names>WJ</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name></person-group><article-title>Comparative studies of Toll-like receptor signalling using zebrafish</article-title><source>Dev Comp Immunol</source><year>2014</year><volume>46</volume><issue>1</issue><fpage>35</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2014.02.003</pub-id><pub-id pub-id-type="pmid">24560981</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>Korbee</surname><given-names>CJ</given-names></name><name><surname>Lamers</surname><given-names>GE</given-names></name><name><surname>Tengeler</surname><given-names>AC</given-names></name><name><surname>Hosseini</surname><given-names>R</given-names></name><name><surname>Haks</surname><given-names>MC</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>The DNA damage-regulated autophagy modulator DRAM1 links mycobacterial recognition via TLR-MYD88 to autophagic defense</article-title><source>Cell Host Microbe</source><year>2014</year><volume>15</volume><issue>6</issue><fpage>753</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.05.005</pub-id><pub-id pub-id-type="pmid">24922577</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>van Soest</surname><given-names>JJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Functional analysis of a zebrafish myd88 mutant identifies key transcriptional components of the innate immune system</article-title><source>Dis Models Mech</source><year>2013</year><volume>6</volume><issue>3</issue><fpage>841</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1242/dmm.010843</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Marin-Juez</surname><given-names>R</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name></person-group><article-title>Common and specific downstream signaling targets controlled by Tlr2 and Tlr5 innate immune signaling in zebrafish</article-title><source>BMC Genomics</source><year>2015</year><volume>16</volume><fpage>547</fpage><pub-id pub-id-type="doi">10.1186/s12864-015-1740-9</pub-id><?supplied-pmid 4514945?><pub-id pub-id-type="pmid">26208853</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Preston-Hurlburt</surname><given-names>P</given-names></name><name><surname>Kopp</surname><given-names>E</given-names></name><name><surname>Stadlen</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Janeway</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group><article-title>MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways</article-title><source>Mol Cell</source><year>1998</year><volume>2</volume><issue>2</issue><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80136-7</pub-id><pub-id pub-id-type="pmid">9734363</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Palsson-McDermott</surname><given-names>EM</given-names></name><name><surname>Bowie</surname><given-names>AG</given-names></name><name><surname>Jefferies</surname><given-names>CA</given-names></name><name><surname>Mansell</surname><given-names>AS</given-names></name><name><surname>Brady</surname><given-names>G</given-names></name><name><surname>Brint</surname><given-names>E</given-names></name><name><surname>Dunne</surname><given-names>A</given-names></name><name><surname>Gray</surname><given-names>P</given-names></name><name><surname>Harte</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction</article-title><source>Nature</source><year>2001</year><volume>413</volume><issue>6851</issue><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/35092578</pub-id><pub-id pub-id-type="pmid">11544529</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>BEV</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Lamers</surname><given-names>G</given-names></name><name><surname>Stougaard</surname><given-names>J</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name></person-group><article-title>Intestinal microbiome adjusts the innate immune setpoint during colonization through negative regulation of MyD88</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>4099</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-06658-4</pub-id><?supplied-pmid 6173721?><pub-id pub-id-type="pmid">30291253</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Okoniewski</surname><given-names>M</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><article-title>Count-based differential expression analysis of RNA sequencing data using R and Bioconductor</article-title><source>Nat Protocols</source><year>2013</year><volume>8</volume><issue>9</issue><fpage>1765</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.099</pub-id><pub-id pub-id-type="pmid">23975260</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clay</surname><given-names>H</given-names></name><name><surname>Volkman</surname><given-names>HE</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death</article-title><source>Immunity</source><year>2008</year><volume>29</volume><issue>2</issue><fpage>283</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.06.011</pub-id><?supplied-pmid 3136176?><pub-id pub-id-type="pmid">18691913</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Boland</surname><given-names>R</given-names></name><name><surname>Bebelman</surname><given-names>JP</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name><name><surname>Siderius</surname><given-names>M</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection</article-title><source>Dis Models Mech</source><year>2015</year><volume>8</volume><issue>3</issue><fpage>253</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1242/dmm.017756</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Rougeot J, Torraca V, Zakrzewska A, Kanwal Z, Jansen HJ, Sommer F, Spaink HP, Meijer AH. RNAseq Profiling of Leukocyte Populations in Zebrafish Larvae Reveals a cxcl11 Chemokine Gene as a Marker of Macrophage Polarization During Mycobacterial Infection. Front Immunol. 2019;10:832.</mixed-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikitin</surname><given-names>A</given-names></name><name><surname>Egorov</surname><given-names>S</given-names></name><name><surname>Daraselia</surname><given-names>N</given-names></name><name><surname>Mazo</surname><given-names>I</given-names></name></person-group><article-title>Pathway studio--the analysis and navigation of molecular networks</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><issue>16</issue><fpage>2155</fpage><lpage>2157</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btg290</pub-id><pub-id pub-id-type="pmid">14594725</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><etal/></person-group><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>43</issue><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><?supplied-pmid 16199517?><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotelnikova</surname><given-names>E</given-names></name><name><surname>Yuryev</surname><given-names>A</given-names></name><name><surname>Mazo</surname><given-names>I</given-names></name><name><surname>Daraselia</surname><given-names>N</given-names></name></person-group><article-title>Computational approaches for drug repositioning and combination therapy design</article-title><source>J Bioinform Comput Biol</source><year>2010</year><volume>8</volume><issue>3</issue><fpage>593</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1142/S0219720010004732</pub-id><pub-id pub-id-type="pmid">20556864</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verway</surname><given-names>M</given-names></name><name><surname>Bouttier</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Carrier</surname><given-names>M</given-names></name><name><surname>Calderon</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>BS</given-names></name><name><surname>Devemy</surname><given-names>E</given-names></name><name><surname>Mcintosh</surname><given-names>F</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><issue>6</issue><fpage>e1003407</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003407</pub-id><?supplied-pmid 3675149?><pub-id pub-id-type="pmid">23762029</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leisching</surname><given-names>G</given-names></name><name><surname>Pietersen</surname><given-names>RD</given-names></name><name><surname>Mpongoshe</surname><given-names>V</given-names></name><name><surname>van Heerden</surname><given-names>C</given-names></name><name><surname>van Helden</surname><given-names>P</given-names></name><name><surname>Wiid</surname><given-names>I</given-names></name><name><surname>Baker</surname><given-names>B</given-names></name></person-group><article-title>The Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free Environment: A Global Transcriptomics Approach</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>4</issue><fpage>e0153079</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0153079</pub-id><?supplied-pmid 4824497?><pub-id pub-id-type="pmid">27055235</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubler</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>C</given-names></name><name><surname>Luna</surname><given-names>B</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Amaral</surname><given-names>EP</given-names></name><name><surname>Urbanowski</surname><given-names>M</given-names></name><name><surname>Orandle</surname><given-names>M</given-names></name><name><surname>Bock</surname><given-names>K</given-names></name><name><surname>Ammerman</surname><given-names>NC</given-names></name><name><surname>Cheung</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis</article-title><source>J Infect Dis</source><year>2016</year><volume>213</volume><issue>4</issue><fpage>618</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiv458</pub-id><pub-id pub-id-type="pmid">26416658</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Fleming</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Identification of serum microRNA biomarkers for tuberculosis using RNA-seq</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e88909</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0088909</pub-id><?supplied-pmid 3930592?><pub-id pub-id-type="pmid">24586438</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mvubu</surname><given-names>NE</given-names></name><name><surname>Pillay</surname><given-names>B</given-names></name><name><surname>Gamieldien</surname><given-names>J</given-names></name><name><surname>Bishai</surname><given-names>W</given-names></name><name><surname>Pillay</surname><given-names>M</given-names></name></person-group><article-title>Canonical pathways, networks and transcriptional factor regulation by clinical strains of <italic>Mycobacterium tuberculosis</italic> in pulmonary alveolar epithelial cells</article-title><source>Tuberculosis (Edinb)</source><year>2016</year><volume>97</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2015.12.002</pub-id><pub-id pub-id-type="pmid">26980499</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachmandas</surname><given-names>E</given-names></name><name><surname>Beigier-Bompadre</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>SC</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>van Laarhoven</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ammerdorffer</surname><given-names>A</given-names></name><name><surname>Boutens</surname><given-names>L</given-names></name><name><surname>de Jong</surname><given-names>D</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name><etal/></person-group><article-title>Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against <italic>Mycobacterium tuberculosis</italic> in human and murine cells</article-title><source>Eur J Immunol</source><year>2016</year><volume>46</volume><issue>11</issue><fpage>2574</fpage><lpage>2586</lpage><pub-id pub-id-type="doi">10.1002/eji.201546259</pub-id><?supplied-pmid 5129526?><pub-id pub-id-type="pmid">27624090</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>G</given-names></name><name><surname>Freyer</surname><given-names>D</given-names></name><name><surname>Harhausen</surname><given-names>D</given-names></name><name><surname>Khojasteh</surname><given-names>U</given-names></name><name><surname>Nietfeld</surname><given-names>W</given-names></name><name><surname>Trendelenburg</surname><given-names>G</given-names></name></person-group><article-title>Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke</article-title><source>J Cereb Blood Flow Metab</source><year>2011</year><volume>31</volume><issue>2</issue><fpage>757</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2010.161</pub-id><pub-id pub-id-type="pmid">20842165</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>O</given-names></name><name><surname>Braun</surname><given-names>JS</given-names></name><name><surname>Becker</surname><given-names>D</given-names></name><name><surname>Halle</surname><given-names>A</given-names></name><name><surname>Freyer</surname><given-names>D</given-names></name><name><surname>Dagand</surname><given-names>E</given-names></name><name><surname>Lehnardt</surname><given-names>S</given-names></name><name><surname>Weber</surname><given-names>JR</given-names></name></person-group><article-title>TLR2 mediates neuroinflammation and neuronal damage</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><issue>10</issue><fpage>6476</fpage><lpage>6481</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.10.6476</pub-id><pub-id pub-id-type="pmid">17475877</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>B</given-names></name><name><surname>Gong</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2/NFkappaB pathway in rats with hypoxic-ischemic brain damage</article-title><source>Mol Brain</source><year>2015</year><volume>8</volume><issue>1</issue><fpage>65</fpage><pub-id pub-id-type="doi">10.1186/s13041-015-0157-3</pub-id><?supplied-pmid 4609057?><pub-id pub-id-type="pmid">26475712</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Rockenstein</surname><given-names>E</given-names></name><name><surname>Spencer</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Adame</surname><given-names>A</given-names></name><name><surname>Trejo</surname><given-names>M</given-names></name><name><surname>Stafa</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name></person-group><article-title>Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy</article-title><source>Cell Rep</source><year>2015</year><volume>13</volume><issue>4</issue><fpage>771</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.044</pub-id><?supplied-pmid 4752835?><pub-id pub-id-type="pmid">26489461</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriguchi</surname><given-names>T</given-names></name><name><surname>Hamada</surname><given-names>M</given-names></name><name><surname>Morito</surname><given-names>N</given-names></name><name><surname>Terunuma</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Yokomizo</surname><given-names>T</given-names></name><name><surname>Esaki</surname><given-names>R</given-names></name><name><surname>Kuroda</surname><given-names>E</given-names></name><name><surname>Yoh</surname><given-names>K</given-names></name><etal/></person-group><article-title>MafB is essential for renal development and F4/80 expression in macrophages</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><issue>15</issue><fpage>5715</fpage><lpage>5727</lpage><pub-id pub-id-type="doi">10.1128/MCB.00001-06</pub-id><?supplied-pmid 1592773?><pub-id pub-id-type="pmid">16847325</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauquet</surname><given-names>AT</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Paterson</surname><given-names>AM</given-names></name><name><surname>Mitsdoerffer</surname><given-names>M</given-names></name><name><surname>Ho</surname><given-names>IC</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><article-title>The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells</article-title><source>Nat Immunol</source><year>2009</year><volume>10</volume><issue>2</issue><fpage>167</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/ni.1690</pub-id><pub-id pub-id-type="pmid">19098919</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title>The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><issue>6</issue><fpage>3484</fpage><lpage>3492</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.6.3484</pub-id><?supplied-pmid 2955976?><pub-id pub-id-type="pmid">15749884</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>A</given-names></name><name><surname>Soucie</surname><given-names>E</given-names></name><name><surname>Sarrazin</surname><given-names>S</given-names></name><name><surname>Sieweke</surname><given-names>MH</given-names></name></person-group><article-title>MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages</article-title><source>Science</source><year>2009</year><volume>326</volume><issue>5954</issue><fpage>867</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1126/science.1176056</pub-id><pub-id pub-id-type="pmid">19892988</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PA</given-names></name></person-group><article-title>The tantalizing links between gut microbes and the brain</article-title><source>Nature</source><year>2015</year><volume>526</volume><issue>7573</issue><fpage>312</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1038/526312a</pub-id><pub-id pub-id-type="pmid">26469024</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>DJ</given-names></name><name><surname>Bryda</surname><given-names>EC</given-names></name><name><surname>Gillespie</surname><given-names>CH</given-names></name><name><surname>Ericsson</surname><given-names>AC</given-names></name></person-group><article-title>Microbial modulation of behavior and stress responses in zebrafish larvae</article-title><source>Behav Brain Res</source><year>2016</year><volume>311</volume><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2016.05.040</pub-id><?supplied-pmid 6423445?><pub-id pub-id-type="pmid">27217102</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Abreu</surname><given-names>MS</given-names></name><name><surname>Giacomini</surname><given-names>A</given-names></name><name><surname>Zanandrea</surname><given-names>R</given-names></name><name><surname>Dos Santos</surname><given-names>BE</given-names></name><name><surname>Genario</surname><given-names>R</given-names></name><name><surname>de Oliveira</surname><given-names>GG</given-names></name><name><surname>Friend</surname><given-names>AJ</given-names></name><name><surname>Amstislavskaya</surname><given-names>TG</given-names></name><name><surname>Kalueff</surname><given-names>AV</given-names></name></person-group><article-title>Psychoneuroimmunology and immunopsychiatry of zebrafish</article-title><source>Psychoneuroendocrinology</source><year>2018</year><volume>92</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2018.03.014</pub-id><pub-id pub-id-type="pmid">29609110</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname><given-names>D</given-names></name><name><surname>Brinkman</surname><given-names>NE</given-names></name><name><surname>Keely</surname><given-names>SP</given-names></name><name><surname>Anneken</surname><given-names>EM</given-names></name><name><surname>Catron</surname><given-names>TR</given-names></name><name><surname>Betancourt</surname><given-names>D</given-names></name><name><surname>Wood</surname><given-names>CE</given-names></name><name><surname>Espenschied</surname><given-names>ST</given-names></name><name><surname>Rawls</surname><given-names>JF</given-names></name><name><surname>Tal</surname><given-names>T</given-names></name></person-group><article-title>Microbial colonization is required for normal neurobehavioral development in zebrafish</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>11244</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-10517-5</pub-id><?supplied-pmid 5593827?><pub-id pub-id-type="pmid">28894128</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrelli</surname><given-names>L</given-names></name><name><surname>Aceto</surname><given-names>S</given-names></name><name><surname>Agnisola</surname><given-names>C</given-names></name><name><surname>De Paolo</surname><given-names>S</given-names></name><name><surname>Dipineto</surname><given-names>L</given-names></name><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Menna</surname><given-names>LF</given-names></name><name><surname>Fioretti</surname><given-names>A</given-names></name></person-group><article-title>Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>30046</fpage><pub-id pub-id-type="doi">10.1038/srep30046</pub-id><?supplied-pmid 4945902?><pub-id pub-id-type="pmid">27416816</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naidoo</surname><given-names>CC</given-names></name><name><surname>Nyawo</surname><given-names>GR</given-names></name><name><surname>Wu</surname><given-names>BG</given-names></name><name><surname>Walzl</surname><given-names>G</given-names></name><name><surname>Warren</surname><given-names>RM</given-names></name><name><surname>Segal</surname><given-names>LN</given-names></name><name><surname>Theron</surname><given-names>G</given-names></name></person-group><article-title>The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda</article-title><source>Lancet Respir Med</source><year>2019</year><volume>7</volume><issue>10</issue><fpage>892</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(18)30501-0</pub-id><pub-id pub-id-type="pmid">30910543</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>van Zon</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>Vandenbroucke-Grauls</surname><given-names>CM</given-names></name><name><surname>van der Wel</surname><given-names>NN</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group><article-title>The ESX-5 secretion system of <italic>Mycobacterium marinum</italic> modulates the macrophage response</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><issue>10</issue><fpage>7166</fpage><lpage>7175</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.10.7166</pub-id><pub-id pub-id-type="pmid">18981138</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>ET</given-names></name><name><surname>Shukla</surname><given-names>S</given-names></name><name><surname>Sweet</surname><given-names>DR</given-names></name><name><surname>Wearsch</surname><given-names>PA</given-names></name><name><surname>Tsichlis</surname><given-names>PN</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name></person-group><article-title>Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in <italic>Mycobacterium tuberculosis</italic>-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells</article-title><source>Infect Immun</source><year>2015</year><volume>83</volume><issue>6</issue><fpage>2242</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1128/IAI.00135-15</pub-id><?supplied-pmid 4432743?><pub-id pub-id-type="pmid">25776754</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piermattei</surname><given-names>A</given-names></name><name><surname>Migliara</surname><given-names>G</given-names></name><name><surname>Di Sante</surname><given-names>G</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name><name><surname>Hayrabedyan</surname><given-names>SB</given-names></name><name><surname>Papagna</surname><given-names>A</given-names></name><name><surname>Geloso</surname><given-names>MC</given-names></name><name><surname>Corbi</surname><given-names>M</given-names></name><name><surname>Valentini</surname><given-names>M</given-names></name><name><surname>Sgambato</surname><given-names>A</given-names></name><etal/></person-group><article-title>Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of <italic>Mycobacterium tuberculosis</italic> and Modulates Autoimmune Encephalomyelitis</article-title><source>Front Immunol</source><year>2016</year><volume>7</volume><fpage>191</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00191</pub-id><?supplied-pmid 4878199?><pub-id pub-id-type="pmid">27252700</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>S</given-names></name><name><surname>Hibberd</surname><given-names>ML</given-names></name><name><surname>Hari Dass</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>HE</given-names></name><name><surname>Sahiratmadja</surname><given-names>E</given-names></name><name><surname>Bonnard</surname><given-names>C</given-names></name><name><surname>Alisjahbana</surname><given-names>B</given-names></name><name><surname>Szeszko</surname><given-names>JS</given-names></name><name><surname>Balabanova</surname><given-names>Y</given-names></name><name><surname>Drobniewski</surname><given-names>F</given-names></name><etal/></person-group><article-title>Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis</article-title><source>PLoS Genet</source><year>2008</year><volume>4</volume><issue>10</issue><fpage>e1000218</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1000218</pub-id><?supplied-pmid 2568981?><pub-id pub-id-type="pmid">18927625</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>YF</given-names></name><name><surname>Lin</surname><given-names>TM</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name><name><surname>Su</surname><given-names>PY</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Lin</surname><given-names>MC</given-names></name><name><surname>Eng</surname><given-names>HL</given-names></name></person-group><article-title>Functional polymorphisms of the TLR7 and TLR8 genes contribute to <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Tuberculosis (Edinb)</source><year>2016</year><volume>98</volume><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2016.03.008</pub-id><pub-id pub-id-type="pmid">27156628</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moen</surname><given-names>SH</given-names></name><name><surname>Ehrnstr&#x000f6;m</surname><given-names>B</given-names></name><name><surname>Kojen</surname><given-names>JF</given-names></name><name><surname>Beckwith</surname><given-names>KS</given-names></name><name><surname>Afset</surname><given-names>JE</given-names></name><name><surname>Dam&#x000e5;s</surname><given-names>JK</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Espevik</surname><given-names>T</given-names></name><name><surname>Stenvik</surname><given-names>J</given-names></name></person-group><article-title>Human Toll-like receptor 8 (TLR8) is an important sensor of pyogenic bacteria, and is attenuated by cell surface TLR signaling</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>1209</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.01209</pub-id><?supplied-pmid 6554558?><pub-id pub-id-type="pmid">31214180</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeme</surname><given-names>AE</given-names></name><name><surname>Robinson</surname><given-names>RT</given-names></name></person-group><article-title>Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice</article-title><source>J Immunol</source><year>2016</year><volume>196</volume><issue>3</issue><fpage>1293</fpage><lpage>1304</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500931</pub-id><?supplied-pmid 5289224?><pub-id pub-id-type="pmid">26729807</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>BH</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Ochoa</surname><given-names>MT</given-names></name><name><surname>Schauber</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Meinken</surname><given-names>C</given-names></name><etal/></person-group><article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response</article-title><source>Science</source><year>2006</year><volume>311</volume><issue>5768</issue><fpage>1770</fpage><lpage>1773</lpage><pub-id pub-id-type="doi">10.1126/science.1123933</pub-id><pub-id pub-id-type="pmid">16497887</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haire</surname><given-names>RN</given-names></name><name><surname>Cannon</surname><given-names>JP</given-names></name><name><surname>O'Driscoll</surname><given-names>ML</given-names></name><name><surname>Ostrov</surname><given-names>DA</given-names></name><name><surname>Mueller</surname><given-names>MG</given-names></name><name><surname>Turner</surname><given-names>PM</given-names></name><name><surname>Litman</surname><given-names>RT</given-names></name><name><surname>Litman</surname><given-names>GW</given-names></name><name><surname>Yoder</surname><given-names>JA</given-names></name></person-group><article-title>Genomic and functional characterization of the diverse immunoglobulin domain-containing protein (DICP) family</article-title><source>Genomics</source><year>2012</year><volume>99</volume><issue>5</issue><fpage>282</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2012.02.004</pub-id><?supplied-pmid 3351558?><pub-id pub-id-type="pmid">22386706</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Nunez</surname><given-names>I</given-names></name><name><surname>Wcisel</surname><given-names>DJ</given-names></name><name><surname>Litman</surname><given-names>GW</given-names></name><name><surname>Yoder</surname><given-names>JA</given-names></name></person-group><article-title>Multigene families of immunoglobulin domain-containing innate immune receptors in zebrafish: deciphering the differences</article-title><source>Dev Comp Immunol</source><year>2014</year><volume>46</volume><issue>1</issue><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2014.02.004</pub-id><?supplied-pmid 4028400?><pub-id pub-id-type="pmid">24548770</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blander</surname><given-names>JM</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title>Regulation of Phagosome Maturation by Signals from Toll-Like Receptors</article-title><source>Science</source><year>2004</year><volume>304</volume><issue>5673</issue><fpage>1014</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1126/science.1096158</pub-id><pub-id pub-id-type="pmid">15143282</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>MJ</given-names></name><name><surname>Chuquimia</surname><given-names>OD</given-names></name><name><surname>Petursdottir</surname><given-names>DH</given-names></name><name><surname>Periolo</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name></person-group><article-title>Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><issue>11</issue><fpage>4649</fpage><lpage>4656</lpage><pub-id pub-id-type="doi">10.1128/IAI.05724-11</pub-id><?supplied-pmid 3257930?><pub-id pub-id-type="pmid">21844233</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernut</surname><given-names>A</given-names></name><name><surname>Herrmann</surname><given-names>JL</given-names></name><name><surname>Kissa</surname><given-names>K</given-names></name><name><surname>Dubremetz</surname><given-names>JF</given-names></name><name><surname>Gaillard</surname><given-names>JL</given-names></name><name><surname>Lutfalla</surname><given-names>G</given-names></name><name><surname>Kremer</surname><given-names>L</given-names></name></person-group><article-title>Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><issue>10</issue><fpage>E943</fpage><lpage>E952</lpage><pub-id pub-id-type="doi">10.1073/pnas.1321390111</pub-id><?supplied-pmid 3956181?><pub-id pub-id-type="pmid">24567393</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Loynes</surname><given-names>CA</given-names></name><name><surname>Trushell</surname><given-names>DM</given-names></name><name><surname>Elworthy</surname><given-names>S</given-names></name><name><surname>Ingham</surname><given-names>PW</given-names></name><name><surname>Whyte</surname><given-names>MK</given-names></name></person-group><article-title>A transgenic zebrafish model of neutrophilic inflammation</article-title><source>Blood</source><year>2006</year><volume>108</volume><issue>13</issue><fpage>3976</fpage><lpage>3978</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-05-024075</pub-id><pub-id pub-id-type="pmid">16926288</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Zakrzewska</surname><given-names>A</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial infection and the role of innate and adaptive immune components</article-title><source>Mol Immunol</source><year>2009</year><volume>46</volume><issue>11&#x02013;12</issue><fpage>2317</fpage><lpage>2332</lpage><?supplied-pmid 19409617?><pub-id pub-id-type="pmid">19409617</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benard</surname><given-names>EL</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Ellett</surname><given-names>F</given-names></name><name><surname>Lieschke</surname><given-names>GJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Infection of zebrafish embryos with intracellular bacterial pathogens</article-title><source>J Vis Exp</source><year>2012</year><volume>61</volume><fpage>2</fpage></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockhammer</surname><given-names>OW</given-names></name><name><surname>Zakrzewska</surname><given-names>A</given-names></name><name><surname>Hegedus</surname><given-names>Z</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><issue>9</issue><fpage>5641</fpage><lpage>5653</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900082</pub-id><pub-id pub-id-type="pmid">19380811</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoop</surname><given-names>EJM</given-names></name><name><surname>Schipper</surname><given-names>T</given-names></name><name><surname>Rosendahl Huber</surname><given-names>SK</given-names></name><name><surname>Nezhinsky</surname><given-names>AE</given-names></name><name><surname>Verbeek</surname><given-names>FJ</given-names></name><name><surname>Gurcha</surname><given-names>SS</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Vandenbroucke-Grauls</surname><given-names>CMJE</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name></person-group><article-title>Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma formation reveals a newly identified ESX-1 component</article-title><source>Dis Models Mech</source><year>2011</year><volume>4</volume><issue>4</issue><fpage>526</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1242/dmm.006676</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Soest</surname><given-names>JJ</given-names></name><name><surname>Stockhammer</surname><given-names>OW</given-names></name><name><surname>Ordas</surname><given-names>A</given-names></name><name><surname>Bloemberg</surname><given-names>GV</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><article-title>Comparison of static immersion and intravenous injection systems for exposure of zebrafish embryos to the natural pathogen Edwardsiella tarda</article-title><source>BMC Immunol</source><year>2011</year><volume>12</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/1471-2172-12-58</pub-id><?supplied-pmid 3206475?><pub-id pub-id-type="pmid">22003892</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x02212;Delta Delta C(T)) Method</article-title><source>Methods</source><year>2001</year><volume>25</volume><issue>4</issue><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="other">Marin-Juez R, Jong-Raadsen S, Yang S, Spaink HP. Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish. J Endocrinol. 2014;222:229-41.</mixed-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veneman</surname><given-names>W</given-names></name><name><surname>de Sonneville</surname><given-names>J</given-names></name><name><surname>van der Kolk</surname><given-names>KJ</given-names></name><name><surname>Ordas</surname><given-names>A</given-names></name><name><surname>Al-Ars</surname><given-names>Z</given-names></name><name><surname>Meijer</surname><given-names>A</given-names></name><name><surname>Spaink</surname><given-names>H</given-names></name></person-group><article-title>Analysis of RNAseq datasets from a comparative infectious disease zebrafish model using GeneTiles bioinformatics</article-title><source>Immunogenetics</source><year>2015</year><volume>67</volume><issue>3</issue><fpage>135</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/s00251-014-0820-3</pub-id><pub-id pub-id-type="pmid">25503064</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><issue>12</issue><fpage>550</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><?supplied-pmid 4302049?><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotelnikova</surname><given-names>E</given-names></name><name><surname>Shkrob</surname><given-names>MA</given-names></name><name><surname>Pyatnitskiy</surname><given-names>MA</given-names></name><name><surname>Ferlini</surname><given-names>A</given-names></name><name><surname>Daraselia</surname><given-names>N</given-names></name></person-group><article-title>Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy</article-title><source>PLoS Comput Biol</source><year>2012</year><volume>8</volume><issue>2</issue><fpage>e1002365</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002365</pub-id><?supplied-pmid 3271016?><pub-id pub-id-type="pmid">22319435</pub-id></element-citation></ref></ref-list></back></article>